NCT04601298
The Risk Stratification of Papillary Thyroid Cancer With AUS/FLUS by FNA No drug interventions Not Available Not Available completed NCT06518577
Immunogenicity of Influenza Vaccinations prevention 4 not_yet_recruiting NCT06501963
Revealing Protective Immunity to Influenza Using Systems Immunology basic_science 4 not_yet_recruiting NCT06482359
Lot Consistency Study of COVID-19 and Influenza Combination Vaccine prevention 2 / 3 not_yet_recruiting NCT06259487
Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis. No drug interventions prevention Not Available recruiting NCT06252051
Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD) No drug interventions prevention 4 completed NCT06254313
The Role of Cxcr4Hi neutrOPhils in InflueNza No drug interventions Not Available Not Available not_yet_recruiting NCT06141824
Performance Evaluation of the Lucira COVID-19 & Flu Test No drug interventions diagnostic Not Available completed NCT06048406
Effect of Health Education on Promoting Influenza Vaccination Health Literacy No drug interventions health_services_research Not Available recruiting NCT06077045
Uptake of the Childhood Live Attenuated Influenza Vaccine (LAIV) and Influenza-related Healthcare Resource Use in England During the 2012 to 2022 Flu Seasons; a Retrospective, Observational Study in the CPRD and HES Databases No drug interventions Not Available Not Available completed NCT05945485
A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults No drug interventions prevention 1 recruiting NCT05765396
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies No drug interventions Not Available Not Available recruiting NCT05645900
A Clinical Trial of an Quadrivalent Influenza Virus Subunit Vaccine in Chinese Children Aged 6 to 35 Months No drug interventions prevention 3 completed NCT05648448
A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza treatment 2 recruiting NCT05508698
Flu Shot Pre-visit Questionnaire No drug interventions prevention Not Available completed NCT05493787
Nudging Flu Vaccination by Making it Easy for Patients to Schedule a Flu Shot No drug interventions prevention Not Available completed NCT05492786
High-risk Influenza Vaccine Alert No drug interventions prevention Not Available completed NCT05535777
Patient Portal Flu Vaccine Reminders_RCT 5 (LADHS) No drug interventions health_services_research Not Available completed NCT06160128
COVID-19 Pharmacotherapy Effectiveness in the VA Healthcare System No drug interventions Not Available Not Available recruiting NCT05284799
Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers. prevention 2 completed NCT05277298
Household Study of COVID-19, Influenza and RSV Burden, Transmission Dynamics and Viral Interaction in South Africa No drug interventions Not Available Not Available unknown_status NCT05152017
The Objectives of This Study Are Study the Safety, Reactogenicity and Obtain Preliminary Data on the Immunogenicity of Flu-M Quadro, 4-valent Inactivated Split Influenza Vaccine, in Healthy Volunteers No drug interventions prevention 1 completed NCT05093998
Study Evaluating the Efficacy and Safety of AV5080 in Patients With Uncomplicated Influenza No drug interventions treatment 3 unknown_status NCT05040659
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2 No drug interventions Not Available Not Available recruiting NCT05012163
Lottery Incentive Nudges to Increase Influenza Vaccinations No drug interventions prevention Not Available completed NCT05019456
Exercise and COVID-19 Viral T-cell Immunity No drug interventions basic_science Not Available unknown_status NCT04772170
Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies No drug interventions Not Available Not Available recruiting NCT04798677
Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine No drug interventions other Not Available completed NCT04974775
Swecrit Biobank - Blood Samples From Critically Ill Patients and Healthy Controls No drug interventions Not Available Not Available active_not_recruiting NCT06161454
Xofluza-Wearables Feasibility-Study treatment 4 recruiting NCT04978454
Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza Strain No drug interventions other 1 completed NCT04712539
Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients treatment 2 recruiting NCT04664075
Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19) No drug interventions Not Available Not Available terminated NCT04611061
Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers No drug interventions Not Available Not Available completed NCT04610047
Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness No drug interventions treatment 2 completed NCT04533061
Influenza Vaccine in Lung Transplant Patients - T Cells No drug interventions Not Available Not Available completed NCT04282135
Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling No drug interventions Not Available Not Available completed NCT04613206
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients prevention 2 recruiting NCT04232956
Invasive Pulmonary Aspergillosis and Severe Influenza No drug interventions Not Available Not Available completed NCT04210349
Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of Age No drug interventions prevention 3 completed NCT04192500
Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years prevention 2 completed NCT04141917
Test-and-treat for Influenza in Homeless Shelters No drug interventions prevention 4 terminated NCT04141930
Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle treatment 4 completed NCT04101435
Immunogenicity and Safety Evaluation of QIS in Healthy Subjects prevention 3 completed NCT03753347
TITRE III: Influenza B Immunogenicity Investigation No drug interventions other 4 active_not_recruiting NCT03945825
Flublok or Fluzone With Advax-CpG55.2 or AF03 prevention 1 completed NCT03903718
Evaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat Influenza treatment 2 withdrawn NCT03883113
Efficacy of MVA-NP+M1 in the Influenza H3N2 Human Challenge Model No drug interventions prevention 2 completed NCT03481270
The Oakland Men's Health Disparities Study No drug interventions other Not Available completed NCT03826719
Safety, Tolerability and Immunogenicity of NBP607QIV in Healthy Adult Volunteers No drug interventions prevention 1 / 2 completed NCT03830905
Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI treatment 2 completed NCT03816878
Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals No drug interventions prevention 1 completed NCT03787459
Severe Influenza Trial of ARbidol treatment 3 unknown_status NCT03754686
Oseltamivir Versus Paracetamol for Influenza-like Illness During the Influenza Season treatment 4 unknown_status NCT03760549
Study of the Safety and Immunogenicity of NasoVAX Extension Not Available Not Available completed NCT03734237
A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD No drug interventions prevention 4 active_not_recruiting NCT03699839
Reducing the Burden of Influenza After Solid-Organ Transplantation No drug interventions prevention 2 / 3 completed NCT06163677
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza. No drug interventions Not Available Not Available withdrawn NCT03599739
Adjuvanted Influenza Vaccination Year 2 Follow-On Survey No drug interventions Not Available Not Available completed NCT04548518
Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Elderly No drug interventions prevention 3 unknown_status NCT04626622
Kagocel® for the Prevention of ARVI and Influenza in Young People No drug interventions Not Available Not Available completed NCT05030324
A Study to Evaluate the Safety, Tolerability and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections treatment 2 completed NCT05581407
Safety, Tolerability, and Immunogenicity of TETRALITE, a Novel Adjuvanted, Low-dose Influenza Vaccin No drug interventions prevention 1 completed NCT05082688
Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX) basic_science 2 completed NCT05565586
Impact of High Dietary Fiber on Microbiome and Vaccine Responses No drug interventions treatment Not Available recruiting NCT05608005
Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older No drug interventions prevention 1 / 2 completed NCT05612893
Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study No drug interventions Not Available Not Available not_yet_recruiting NCT05832333
Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra®) in Subjects Aged 6 to 35 Months No drug interventions Not Available Not Available completed NCT05832307
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program No drug interventions health_services_research Not Available not_yet_recruiting NCT06286488
Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza prevention 4 active_not_recruiting NCT05866237
COVID-19 Vaccine Uptake Amongst Underserved Populations in East London No drug interventions prevention Not Available recruiting NCT06118151
Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and Older prevention 1 completed NCT03474887
Digital Online Consultations - Effects on Antibiotic Prescribing and Health Care Utilization in Primary Care No drug interventions Not Available Not Available completed NCT03450915
A Pivotal Trial to Assess the Safety and Clinical Efficacy of the M-001 as a Standalone Universal Flu Vaccine No drug interventions treatment 3 completed NCT03394209
A Pharmacokinetics Study of Favipiravir in Patients With Severe Influenza treatment 2 completed NCT03367624
Epidemiology of Post-influenza Bacterial Pneumonia Due to a Panton-Valentine Leukocidin Positive Staphylococcus Aureus No drug interventions Not Available Not Available unknown_status NCT03336619
A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza treatment 3 completed NCT03330899
Safety and Immunogencity of H7N9 Influenza Antigen With 2 Adjuvant Formulations in Healthy Adults in Brazil No drug interventions prevention 1 completed NCT03328325
Age and Response to Flu Vaccines No drug interventions prevention 4 completed NCT03327987
Early Flu Shots in SOT No drug interventions Not Available Not Available withdrawn NCT03312699
Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort basic_science 1 completed NCT03318315
Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4 No drug interventions prevention 2 completed NCT03293498
Evaluation of the Safety and Immunogenicity of a Recombinant Trivalent Nanoparticle Influenza Vaccine With Matrix M-1 Adjuvant (NanoFlu) prevention 1 / 2 completed NCT03287830
Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine No drug interventions health_services_research Not Available completed NCT03266237
The Immune Response to Influenza Vaccinations in Elderly Individuals prevention 4 completed NCT03068949
Comparison of Three Licensed Influenza Vaccines basic_science 4 completed NCT04044352
H1N1v Virus Challenge Study in Healthy Subjects basic_science 1 completed NCT02746211
Influenza Challenge Study in Healthy Volunteers No drug interventions basic_science 1 / 2 completed NCT02762851
Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE) treatment 4 unknown_status NCT02860039
High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant No drug interventions prevention 2 active_not_recruiting NCT02876159
The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination No drug interventions prevention 4 completed NCT02921997
H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses prevention 2 completed NCT02949011
Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications treatment 3 completed NCT03022435
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 4, 2012 basic_science 4 completed NCT03023709
Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032) basic_science 4 terminated NCT03233217
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years No drug interventions prevention 1 / 2 completed NCT03023683
Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024) basic_science 4 completed NCT02882100
Adjuvanted Influenza Vaccination in U.S. Nursing Homes prevention 4 completed NCT02686398
Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis prevention 4 completed NCT02583256
Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine in Children Previously Vaccinated in Trial V118_05 (NCT01964989) No drug interventions prevention 3 completed NCT02592486
The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine prevention 4 completed NCT02623075
Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients treatment 1 / 2 completed NCT02612922
Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza treatment 3 completed NCT02624219
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults prevention 1 completed NCT02658409
A Multicenter, Double-blind, Parallel, Non-inferiority, Phase III Study prevention 3 unknown_status NCT02563093
Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults prevention 4 completed NCT02572583
A Clinical Study of Treating Influenza With Liugan Shuangjie Heji treatment 1 / 2 unknown_status NCT02665871
Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older No drug interventions prevention 1 unknown_status NCT02541253
A Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children No drug interventions prevention 3 completed NCT02451358
Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in India No drug interventions prevention 3 completed NCT02464163
Trial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older No drug interventions prevention 1 / 2 completed NCT02487147
Evaluation of Free Air Portable Air Powered Respirator No drug interventions prevention Not Available completed NCT02597647
Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza Infection No drug interventions basic_science 1 completed NCT02392858
Severe Influenza Cohort No drug interventions diagnostic Not Available completed NCT02381418
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season prevention 3 completed NCT02459171
Household Transmission of Zoonotic Influenza Viruses in a Cohort of Egyptian Poultry Growers No drug interventions Not Available Not Available completed NCT02644018
Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o. treatment 3 completed NCT02468115
Influenza Challenge Study of VIS410 in Healthy Volunteers treatment 2 completed NCT02293863
A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection treatment 2 completed NCT02293317
Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIV No drug interventions prevention 2 completed NCT02258334
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults prevention 4 completed NCT02267733
Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients prevention 1 completed NCT02266277
System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts No drug interventions health_services_research Not Available completed NCT02269007
A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in China No drug interventions prevention 1 completed NCT02269852
The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine No drug interventions prevention 4 completed NCT02285998
Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age prevention 3 completed NCT02232945
Banlangen Granules Anti-seasonal Influenza Study treatment 4 unknown_status NCT02215863
Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years prevention 4 completed NCT02136017
Post-License Safety Evaluation of Influenza Virus Vaccine No drug interventions Not Available Not Available completed NCT02148328
Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults prevention 1 completed NCT02148211
Fluarix/ FluLaval/ Fluarix Quadrivalent/ FluLaval Quadrivalent Vaccine Pregnancy Registry No drug interventions Not Available Not Available completed NCT02124096
Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs No drug interventions Not Available Not Available completed NCT02035696
Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old No drug interventions prevention 1 / 2 completed NCT02026349
Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316 treatment 3 completed NCT01987011
Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers No drug interventions prevention 3 completed NCT01992107
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old No drug interventions prevention 3 completed NCT01945424
Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry No drug interventions Not Available Not Available completed NCT01916759
Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda basic_science Not Available completed NCT01911754
Japanese Pediatric H5N1 Vaccine Study No drug interventions prevention 3 completed NCT01933048
Self-Administered Nasal Influenza Feasibility Study other 4 completed NCT01893177
Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains (2013-14) No drug interventions prevention 3 completed NCT01906593
A Post-marketing Safety Study of Beijing Tiantan Biological's Influenza Virus Vaccine in Elderly No drug interventions Not Available Not Available completed NCT01884519
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older prevention 3 completed NCT01878825
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older prevention 3 completed NCT01857206
Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age No drug interventions prevention 3 completed NCT01854632
Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in Senegal No drug interventions prevention 3 completed NCT01774032
H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and Older No drug interventions prevention 3 completed NCT01773928
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived) prevention 3 completed NCT01736709
The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine No drug interventions prevention 4 completed NCT01767337
Intracutaneous Delivery of Varied Dose Volumes of Saline No drug interventions prevention Not Available completed NCT01740063
Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza treatment 2 completed NCT01747148
Testing the AVI-7100 Flu Drug in Healthy Volunteers No drug interventions treatment 1 completed NCT01702454
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345 prevention 3 completed NCT01728753
T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza treatment 1 / 2 completed NCT01711736
Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age prevention 3 completed NCT01659086
Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age No drug interventions prevention 1 completed NCT01715909
A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection treatment 1 completed NCT01698177
Optimizing Influenza Vaccination in Surgical Oncology Patients No drug interventions health_services_research 4 unknown_status NCT01690637
Panama and El Salvador Children's Oseltamivir Study treatment 4 terminated NCT01658800
Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 No drug interventions prevention 1 completed NCT01653015
Live Versus Inactivated Influenza Vaccine Study in Hutterite Children prevention 4 completed NCT01688297
Safety Study of an Oral Vaccine to Prevent Seasonal Influenza No drug interventions prevention 1 completed NCT01673425
Evaluating Immune Response to Seasonal FluMist in Healthy Adults basic_science Not Available terminated NCT01649713
Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season No drug interventions prevention 4 completed NCT01664793
From Innovation to Solutions: Childhood Influenza Vaccination Planning No drug interventions prevention Not Available completed NCT01617239
Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine No drug interventions prevention 1 completed NCT01582633
Assessment of Needle-free Disposable-syringe Jet Injector (DSJI) ID Dose-sparing of Pandemic A H1N1 Influenza Vaccine No drug interventions prevention 2 / 3 unknown_status NCT01609998
Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents No drug interventions prevention 1 completed NCT01579916
A Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults No drug interventions prevention 4 completed NCT01610245
Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza treatment 3 completed NCT01554813
Clinical Trial of Inactivated Influenza Vaccine (0.5ml Formulation) No drug interventions prevention 3 completed NCT01545349
Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine Not Available 1 completed NCT01521416
Cost of Illness Associated With Influenza in the UK No drug interventions Not Available Not Available completed NCT01520935
Influenza Burden Assessment in the United Kingdom, 1996-2008 No drug interventions Not Available Not Available completed NCT01456234
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS) health_services_research 4 terminated NCT01484522
Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth Not Available Not Available completed NCT01465035
A Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza Vaccine No drug interventions prevention 1 completed NCT01427309
A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults prevention 4 completed NCT01424371
Adjuvanted Influenza Vaccine Effectiveness in the Elderly (65+Yrs) No drug interventions Not Available Not Available unknown_status NCT01430819
Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults prevention 4 completed NCT01386424
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols No drug interventions Not Available Not Available recruiting NCT01411358
Immunogenicity and Safety of AdimFlu-S 2011-2012 in Non-Elderly Adult and Elderly Subjects No drug interventions prevention Not Available completed NCT01416597
A Systematic Review of Studies of the Effect of Influenza Vaccine Against Mismatched Strains No drug interventions Not Available Not Available completed NCT01379937
A Study to Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children prevention 3 completed NCT01375985
Safety Study of Single Administration Intravenous Treatment for Influenza treatment 1 terminated NCT01317745
H5N1 Mix and Match With MF59 No drug interventions prevention 1 completed NCT01342796
Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects No drug interventions prevention 2 completed NCT01322516
Outcomes of Pandemic Influenza in Pregnancy No drug interventions Not Available Not Available unknown_status NCT01310413
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age prevention 3 completed NCT01306253
A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2009/2010 Influenza Virus Strains for the Northern Hemisphere No drug interventions treatment 4 completed NCT01282177
Influenza Vaccine Safety and Effectiveness in Healthcare Providers No drug interventions Not Available Not Available completed NCT01306305
A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere No drug interventions treatment 4 completed NCT01304771
Safety of Synbiotics as Adjuvant to Influenza Vaccine in Elderly No drug interventions Not Available 1 completed NCT01235000
TIV Infant/Toddler Response Evaluation - Follow-up for Influenza B Boost No drug interventions Not Available Not Available unknown_status NCT01229397
Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V No drug interventions prevention 3 completed NCT01258842
Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults No drug interventions prevention 3 unknown_status NCT01229371
Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers No drug interventions prevention 3 completed NCT01249833
Effect of Oseltamivir on Cognitive Function in Subjects With Influenza treatment 4 completed NCT01248715
Rapid Empiric Treatment With Oseltamivir Study (RETOS) treatment 4 completed NCT01239537
Swine Flu (Influenza A H1N1) Follow on Vaccine Study No drug interventions Not Available Not Available completed NCT01226758
Influenza Vaccine Challenge Study in Healthy Subjects No drug interventions prevention 1 completed NCT01196975
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults prevention 3 completed NCT01210898
Immunogenicity and Safety of V70P5 Revaccination Subjects No drug interventions prevention 3 completed NCT01224613
Study to Compare Self-administered and Nurse-administered Intradermal Influenza Vaccine prevention 4 completed NCT01196988
Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children No drug interventions prevention 3 completed NCT01192737
"COhort Study on A/H1N1 FLU During PREGnancy" No drug interventions Not Available Not Available completed NCT01190215
Immunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTM No drug interventions prevention 4 completed NCT01173224
Influenza Antiviral DAS181-F03 treatment 1 completed NCT01181336
Phase 1b Influenza Vaccine Study in Healthy Subjects No drug interventions prevention 1 completed NCT01204671
Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A) No drug interventions prevention 3 completed NCT01146119
Further Investigation of an Intramuscular Influenza Vaccine (Multimeric-001) No drug interventions treatment 2 completed NCT01146899
FluAlert: Influenza Vaccine Alerts for Providers in the Electronic Health Record No drug interventions health_services_research Not Available completed NCT01160237
Study to Evaluate the Immune Response and the Safety of Fluarix TM/ Influsplit SSW® 2010/2011 or Pandemrix TM No drug interventions prevention 3 terminated NCT01146353
Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy No drug interventions Not Available Not Available withdrawn NCT01140009
Safety and Protectiveness of the Seasonal Influenza Vaccine for 2010-2011 prevention 2 completed NCT01144299
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults prevention 3 completed NCT01121822
Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intramuscular Route) No drug interventions prevention 3 completed NCT01089816
Rapid Diagnostic Test for Influenza No drug interventions Not Available Not Available completed NCT01089400
Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage No drug interventions Not Available Not Available completed NCT01066377
PRIMAGE (Probiotics, Immunity and Ageing) No drug interventions Not Available Not Available unknown_status NCT01053377
A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing Homes prevention 4 unknown_status NCT01063933
Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza treatment 1 / 2 withdrawn NCT01056185
Respiratory Virus Hospitalization Study (FLU 003 Plus) No drug interventions Not Available Not Available recruiting NCT01063088
Adult Safety Study of 2009/2010 Seasonal Influenza Vaccine No drug interventions prevention 3 completed NCT00992433
H1N1 Vaccine at Two Dose Levels in HIV Positive Adults No drug interventions prevention 2 completed NCT01059617
Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults prevention 1 completed NCT00992719
Novartis H1N1 Vaccine in Pregnant Women No drug interventions prevention 2 completed NCT01037205
Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza treatment 2 completed NCT01023711
Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus prevention Not Available completed NCT01040078
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month No drug interventions prevention 3 unknown_status NCT01035749
Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years No drug interventions prevention 2 completed NCT01014806
Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adults No drug interventions prevention 2 completed NCT01024400
Immunogenicity and Safety of an Inactivated Non-adjuvanted A(H1N1)v Influenza Vaccine in Pregnant Women No drug interventions prevention 2 completed NCT01021098
Acute Respiratory Infection Consortium No drug interventions Not Available Not Available active_not_recruiting NCT01010893
Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine No drug interventions prevention Not Available completed NCT00956449
Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects No drug interventions prevention 2 completed NCT00956111
A Clinical Trial With Influenza A/H1N1 Vaccines No drug interventions prevention 4 completed NCT01003145
Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Adults and Elders prevention Not Available completed NCT00942071
A Study to Assess the Safety and Immunogenicity of a New Influenza Vaccine Candidate MVA-NP+M1 in Healthy Adults No drug interventions prevention 1 completed NCT01003418
Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children prevention 2 terminated NCT01001325
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza? health_services_research 3 completed NCT00996970
Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons No drug interventions Not Available Not Available completed NCT00980447
Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults No drug interventions prevention 2 completed NCT00959049
A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population prevention 3 completed NCT00961337
Evaluation of a School-based Influenza Vaccination Program prevention 4 completed NCT00964158
Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A) No drug interventions prevention 3 completed NCT00973349
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults No drug interventions prevention 2 / 3 completed NCT00905125
Influenza Vaccine in Pregnant Women prevention 2 completed NCT00963430
H1N1 Vaccine in Pregnant Women No drug interventions prevention 2 completed NCT00921947
Comparative Safety and Immunogenicity of 1.0 µg Intramuscular (i.m.) and 2.0 µg Subcutaneous (s.c.) Dosing With VAX102 (M2e-flagellin) Universal Influenza Vaccine in Healthy Adults No drug interventions prevention 1 / 2 completed NCT00912496
Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59 No drug interventions prevention 1 completed NCT00971425
Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1) prevention 3 completed NCT00964951
CSL H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations No drug interventions prevention 2 withdrawn NCT00972517
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children No drug interventions prevention 3 completed NCT00943488
CSL H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations No drug interventions prevention 2 completed NCT00951041
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults No drug interventions prevention 2 completed NCT00943878
Sanofi H1N1 + TIV - Adults and Elderly No drug interventions prevention 2 completed NCT00954798
A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly No drug interventions prevention 2 completed NCT00893906
Inactivated Influenza Vaccine Effectiveness in Tropical Africa prevention 4 completed NCT00936013
Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study treatment 4 unknown_status NCT00934245
Direct and Indirect Protection by Influenza Vaccine Given to Children in India prevention 4 completed NCT00915187
Safety and Immunogenicity Study of Intramuscular CCS/C-adjuvanted Influenza Vaccine in Elderly No drug interventions prevention 2 completed NCT00867139
TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients treatment 1 / 2 completed NCT00848848
Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older No drug interventions prevention 1 completed NCT00833885
Tolerability and Measurability of the Efficacy of Non Pharmaceutical Measures to Prevent Seasonal Influenza No drug interventions prevention Not Available completed NCT00819013
Safety Study of Recombinant M2e Influenza-A Vaccine in Healthy Adults prevention 1 completed NCT00812019
Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old) No drug interventions prevention 1 completed NCT00826709
Prospective Evaluation of the Fluid Rapid Influenza Test No drug interventions diagnostic 3 suspended NCT00800605
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection No drug interventions prevention 3 completed NCT00766285
High Dose Influenza in Immunosuppressed Subjects No drug interventions prevention 2 withdrawn NCT00741806
Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults No drug interventions prevention 1 completed NCT00743275
A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination prevention 4 completed NCT00727428
Immunogenicity and Safety of GSK Biologicals' FluLaval® TF prevention 1 completed NCT00731393
Immuno & Reacto of TF Trivalent Influenza Split Vaccine 2003/04 or of Std Formulation Influsplit SSW®/Fluarix™ 2003/04 prevention 3 completed NCT00714285
Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults. No drug interventions prevention 1 completed NCT00703053
H5N1 Priming and Boosting Strategies No drug interventions prevention 2 completed NCT00734175
Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine No drug interventions prevention 1 completed NCT00707941
Oseltamivir Randomised Controlled Efficacy Trial treatment 3 completed NCT00700193
A Study of the Safety, Tolerability & Immunogenicity of CSL Limited's Influenza Virus Vaccine In a Paediatric Population No drug interventions prevention 3 completed NCT00694213
Pandemic Influenza Plasmid DNA Vaccines (Needle-Free) No drug interventions prevention 1 completed NCT00645411
Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents No drug interventions prevention 2 / 3 completed NCT00617851
Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old No drug interventions prevention 3 completed NCT00579345
Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup prevention 3 completed NCT00620815
Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above No drug interventions prevention 2 completed NCT00593970
Influenza Vaccine in Pregnancy Part 2 No drug interventions Not Available Not Available completed NCT00545025
Revaccination With Influenza Vaccine GSK1247446A prevention 2 completed NCT00540228
Study to Evaluate an Influenza Vaccine Candidate prevention 2 completed NCT00546585
Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults prevention 1 / 2 completed NCT00566345
Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII) No drug interventions prevention 3 completed NCT00531700
Testing a Personally Controlled Health Record to Ameliorate Influenza at MIT No drug interventions prevention Not Available completed NCT00532298
Non-Inferiority of Various GSK Bio's Influenza Vaccine Presentations in Adults Aged 65 Years and Over prevention 2 completed NCT00521586
Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine No drug interventions prevention 3 completed NCT00538213
Evaluation of Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults prevention 2 completed NCT00529516
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults prevention 3 completed NCT00491257
A Study of the Immunogenicity and Safety of the 2007-2008 Influenza Vaccine prevention 2 completed NCT00491985
Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children No drug interventions prevention 2 completed NCT00462215
Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived) No drug interventions prevention 3 completed NCT00446628
Project to Investigate Ways to Reduce the Spread of Influenza in Schools and Households With Children No drug interventions prevention Not Available completed NCT00449670
Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults No drug interventions prevention 3 completed NCT00453999
Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza treatment 2 completed NCT00425893
A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households No drug interventions prevention Not Available completed NCT00434733
Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects No drug interventions prevention 3 completed NCT00419861
Inpatient Influenza Surveillance No drug interventions Not Available Not Available completed NCT00389857
Trial to Collect Safety Data and Sera for Immunogenicity Testing prevention 4 completed NCT00412737
A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants prevention 4 completed NCT00388583
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects prevention 2 completed NCT00386113
Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly prevention 2 completed NCT00402649
Open-Label Study of H5 Vaccine in Participants of Protocol 04-077 prevention 1 / 2 completed NCT00382187
Safety and Immunogenicity of Two Adjuvanted and One Non-adjuvanted H5N1 Influenza Vaccine in Adults No drug interventions prevention 2 completed NCT00383071
Development of Immune Globulin Treatment for Avian Flu No drug interventions other 2 terminated NCT00377611
Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™ prevention 4 completed NCT00333398
Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults prevention 3 completed NCT00363870
A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults prevention 4 completed NCT00319098
Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above prevention 3 completed NCT00316628
Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over. No drug interventions prevention 2 completed NCT00337896
T and B Cell Response to Avian Flu Vaccine No drug interventions Not Available Not Available completed NCT00336453
Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics prevention 1 / 2 completed NCT00349037
Study of the Ability of a Flu Vaccine to Prevent Flu Infection No drug interventions prevention 1 completed NCT00321763
Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate prevention 2 completed NCT00318058
Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population prevention 1 completed NCT00304434
Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies. Not Available 4 completed NCT00280033
H5 Adult - Chiron Study of Bird Flu Vaccine prevention 1 / 2 completed NCT00311649
Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities prevention 1 / 2 completed NCT00309647
Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age No drug interventions prevention 1 completed NCT00310206
H5N1 Vaccine Intramuscular Versus Intradermal in Healthy Adults prevention 1 completed NCT00258830
Safety and Immunogenicity of the 2005-2006 Fluzone® Vaccine prevention 4 completed NCT00294788
Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines prevention 1 / 2 unknown_status NCT00294099
H5 Vaccine Alone or With Aluminum Hydroxide in Elderly Adults prevention 1 / 2 completed NCT00231907
A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist prevention 1 completed NCT00253734
Immunogenicity and Safety of Different Doses of Fluzone® Influenza prevention 2 completed NCT00192153
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older No drug interventions prevention 2 completed NCT00197288
Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines No drug interventions prevention 3 completed NCT00192413
Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza prevention 3 completed NCT00192309
Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine. prevention 2 completed NCT00192322
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children No drug interventions prevention 2 completed NCT00192283
Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers No drug interventions prevention 3 completed NCT00192387
Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T) treatment 2 completed NCT00161837
Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2003/2004 No drug interventions prevention 2 / 3 completed NCT00161811
Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005 No drug interventions prevention 2 / 3 completed NCT00115986
A/H5N1in Adult - Aventis prevention 1 / 2 completed NCT00138398
T-cell Response-Flu Risk in Older Adults No drug interventions prevention Not Available completed NCT00142077
Electronic Health Records for Health Promotion No drug interventions prevention Not Available completed NCT05184387
A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness. No drug interventions Not Available Not Available completed NCT06582277
Immunogenicity and Safety of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836 No drug interventions prevention 2 not_yet_recruiting NCT06571747
Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted Engagement No drug interventions other Not Available not_yet_recruiting NCT06560151
BARDA BP-I-23-001 H5 Influenza No drug interventions other 2 recruiting NCT06508320
A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine) No drug interventions prevention 2 active_not_recruiting NCT06507553
Study of Influenza Vaccines Containing an Additional H3 Antigen in Healthy Adult Participants 18 to 49 Years of Age and 60 Years of Age and Older No drug interventions prevention 1 not_yet_recruiting NCT06486766
Effectiveness of SMS Nudging to Increase Coverage of Influenza Vaccination Among the Elderly No drug interventions health_services_research Not Available not_yet_recruiting NCT06229444
Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI No drug interventions prevention Not Available active_not_recruiting NCT06208683
The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School Students prevention 4 active_not_recruiting NCT06178991
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza. No drug interventions prevention 3 active_not_recruiting NCT06075732
ACTIVATE in Public Housing No drug interventions supportive_care Not Available not_yet_recruiting NCT06029933
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years Not Available Not Available recruiting NCT05972174
A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults No drug interventions prevention 1 / 2 completed NCT05944705
Commercially Available Cannabis Products for Immune Support No drug interventions Not Available Not Available recruiting NCT05947071
High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients prevention 2 not_yet_recruiting NCT05781191
Analysis of the Determinants of Adherence to Coadministration of Flu Vaccination With the Booster of COVID-19 Vaccine Not Available Not Available completed NCT05765838
Combined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens. No drug interventions diagnostic Not Available recruiting NCT05509283
Nudging Flu Vaccination in Patients at Moderately High Risk for Flu and Flu-related Complications No drug interventions prevention Not Available completed NCT05494047
Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile No drug interventions prevention 3 unknown_status NCT05474755
To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection No drug interventions treatment 3 completed NCT05389137
To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 Years No drug interventions prevention 4 unknown_status NCT05313893
A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years No drug interventions prevention 4 completed NCT05312294
Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years No drug interventions prevention 3 completed NCT05308212
Tolerability, Safety and Immunogenicity Trial of the FLU-M® Tetra No drug interventions prevention 2 / 3 completed NCT05317767
The Objectives of This Study Are Comparative Assessment of the Tolerability, Safety and Immunogenicity of the Flu-M Vaccine vs. the Ultrix® Vaccine by Single Vaccination of Children Aged 6 to 17 Years. No drug interventions diagnostic 3 completed NCT05290792
Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections screening Not Available completed NCT05170009
Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza treatment 2 / 3 terminated NCT05095844
National Vaccine Adverse Event Reporting Survey and Etiology No drug interventions Not Available Not Available unknown_status NCT05095545
Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With Influenza No drug interventions treatment 2 completed NCT05069714
One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis. treatment 3 completed NCT05060887
Immunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunteers. No drug interventions prevention 2 completed NCT05052190
Patient Portal Flu Vaccine Reminders_RCT 4 No drug interventions health_services_research Not Available completed NCT05048589
Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based Setting No drug interventions treatment 2 completed NCT05012189
Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks prevention 4 active_not_recruiting NCT05009251
Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake No drug interventions prevention Not Available completed NCT04868188
Pharmacokinetics of Voriconazole in Adult ECMO Patients No drug interventions Not Available Not Available recruiting NCT04806529
An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older No drug interventions prevention 2 / 3 withdrawn NCT04801888
Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine prevention 4 completed NCT04782323
Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults No drug interventions prevention 2 completed NCT04761692
Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake No drug interventions health_services_research Not Available withdrawn NCT04982913
Single Dose and Multiple Dose Safety, Tolerability, PK，and Food Effect Study，and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects treatment 1 completed NCT04672577
Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria No drug interventions Not Available Not Available not_yet_recruiting NCT04678271
Assessment, Feedback, Incentive, Exchange (AFIX OB) A Customizable Quality Improvement Intervention to Increase Maternal Vaccine Uptake No drug interventions prevention Not Available completed NCT04651491
Treatment of Influenza and ARVI in Children by Kagocel ® No drug interventions Not Available Not Available completed NCT06274359
Digital Storytelling to Reduce Pediatric Influenza Vaccination Disparities No drug interventions prevention Not Available recruiting NCT04570904
Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness No drug interventions Not Available Not Available completed NCT04533685
Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- UCLA Portal R/R Influenza RCT 3 No drug interventions health_services_research Not Available completed NCT04531787
Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies No drug interventions Not Available Not Available completed NCT04471493
Pediatric and Ambulatory Research in Infectious Diseases No drug interventions Not Available Not Available recruiting NCT04460781
Surveillance Study to Assess the Safety of Flublok Quadrivalent (Influenza Vaccine) in Pregnant Women and Their Offspring Not Available Not Available completed NCT04471038
Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants No drug interventions treatment 1 unknown_status NCT04363359
Clinical Trial of Quadrivalent Influenza Virus Split Vaccine No drug interventions prevention 2 completed NCT04336020
The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study No drug interventions Not Available Not Available recruiting NCT04326309
Audio Data Collection for Identification and Classification of Coughing No drug interventions Not Available Not Available completed NCT04327791
COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1) treatment 2 / 3 recruiting NCT04323137
Encouraging Flu Vaccination Among High-Risk Patients Identified by ML No drug interventions prevention Not Available completed NCT05144464
A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years No drug interventions prevention 4 unknown_status NCT05406180
Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra Inj.) in Subjects Aged 3 Years Old and Above No drug interventions Not Available Not Available completed NCT04239521
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata No drug interventions Not Available Not Available completed NCT04250311
Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults No drug interventions treatment 3 suspended NCT04048369
Impact of Influenza/RSV PCR Point-of-care Testing in the Emergency Medical Service. No drug interventions diagnostic Not Available unknown_status NCT04171128
Procalcitonin Role in Influenza Patients With Regard to Morbidity, Mortality and Antibiotic Use No drug interventions Not Available Not Available completed NCT04143451
Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients prevention 3 unknown_status NCT04144179
Recombinant Influenza Vaccine Containing Different H3 Antigens in Healthy Adults 18 to 30 Years of Age No drug interventions prevention 1 completed NCT04110366
Nasal and Systemic Immune Responses to Nasal Influenza Vaccine No drug interventions basic_science Not Available completed NCT04110990
Retrospective Observational Study on the Epidemiological Characteristics of Influenza Patients No drug interventions Not Available Not Available unknown_status NCT04091880
Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine No drug interventions prevention 4 completed NCT04074928
Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects prevention 3 completed NCT03969212
Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households treatment 3 completed NCT03898973
Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood basic_science 4 withdrawn NCT03888989
Response to Influenza Vaccine During Pregnancy No drug interventions basic_science 1 completed NCT03900988
Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia treatment 3 recruiting NCT03880474
Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults No drug interventions prevention 2 terminated NCT03581903
A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus Vaccine No drug interventions prevention 1 completed NCT03830684
A Randomized, Double-blind, Placebo-controlled, Multicenter and Phase Ⅱa Clinical Trial for the Effectiveness and Safety of Baicalein Tablets in the Treatment of Improve Other Aspects of Healthy Adult With Influenza Fever treatment 2 unknown_status NCT03765437
Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra™) in Subjects Aged 6 Months and Older in Vietnam No drug interventions prevention 3 completed NCT03743688
Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults Not Available Not Available completed NCT03722589
Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP prevention 4 completed NCT03704740
Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months No drug interventions prevention 3 completed NCT03698279
Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age prevention 2 completed NCT03684044
Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza treatment 3 completed NCT03673345
Development of Childhood Anti-Influenza Immunity No drug interventions prevention 4 completed NCT03686514
The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics basic_science 4 terminated NCT03666026
Patient Portal - Flu Reminder Recall No drug interventions health_services_research Not Available completed NCT04385420
Phase 1 Study of ATR-002 treatment 1 completed NCT03600428
Safety of LAIV4 in Children With Asthma No drug interventions prevention 4 completed NCT03603509
Gene Signatures of Influenza Vaccine Responses in Older Adults basic_science 4 completed NCT03594890
Safety and Immune Response of Increasing Doses of OVX836 After Intramuscular or Intranasal Administrations in Healthy Subjects No drug interventions prevention 1 completed NCT05027932
Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine No drug interventions prevention 1 completed NCT05616546
Bone Marrow and Peripheral Blood Immune Responses Study No drug interventions basic_science 4 recruiting NCT05585632
A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old prevention 1 completed NCT05084846
InFLUenza and the HEART An Investigation Into the Acute and Lasting Cardiac Effects of Influenza Infection No drug interventions Not Available Not Available recruiting NCT05087355
Health Status Prior and Post Infection With Influenza or COVID 19: a Population Based Retrospective Analysis of 2016-2021 No drug interventions Not Available Not Available completed NCT05089123
The Objectives of This Study Are Study the Immunogenicity and Safety of the Flu-M [Inactivated Split Influenza Vaccine], vs. the Ultrix® Inactivated Split Influenza Vaccine, in Volunteers Who Are Over 60 Years Old No drug interventions prevention 3 completed NCT05190432
Taxifolin/Ergothioneine and Immune Biomarkers in Healthy Volunteers (TaxEr) No drug interventions basic_science Not Available active_not_recruiting NCT05239403
Association Between Gut Microbiome and Dietary Determinants and Vaccine Response No drug interventions Not Available Not Available recruiting NCT05558462
Pharmacokinetics and Bioequivalence of XC8 10 mg and 40 mg Tablets in Fasted Volunteers No drug interventions other Not Available completed NCT05332899
Influenza Human Challenge Model No drug interventions basic_science 1 recruiting NCT05517174
A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults No drug interventions treatment 4 recruiting NCT05252338
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults No drug interventions prevention 1 completed NCT06342349
A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above. No drug interventions prevention 1 recruiting NCT05606965
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults prevention 2 active_not_recruiting NCT05674370
A Study of the GRIP Influenza and SARS-CoV-2 POC Assays No drug interventions diagnostic Not Available completed NCT05613751
Enhancing Protection Against Influenza and COVID-19 for Pregnant Women and Medically at Risk Children No drug interventions health_services_research Not Available recruiting NCT05666245
DMID 21-0041; Influenza CVD 59000 No drug interventions other Not Available recruiting NCT05755620
A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults No drug interventions prevention 1 recruiting NCT05895955
Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais prevention 1 / 2 active_not_recruiting NCT04439695
Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults No drug interventions prevention 1 completed NCT03180801
Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model No drug interventions prevention 2 completed NCT03186781
Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults No drug interventions prevention 1 completed NCT03163342
Immune Response Following Seasonal Influenza Vaccination No drug interventions diagnostic 4 completed NCT03158038
Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season No drug interventions prevention 4 completed NCT03453801
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection basic_science 1 completed NCT03451656
Prospective System Analysis of the Seasonal Influenza Virus Transmissions and Evolution in the City of Basel Basel No drug interventions Not Available Not Available completed NCT03248960
Ellume.Lab Flu A+B Test and iTreat Flu A+B Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction. No drug interventions diagnostic Not Available completed NCT03413228
Nosocomial Influenza Surveillance 2018 - 2022 No drug interventions Not Available Not Available unknown_status NCT03391193
Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine No drug interventions prevention 3 completed NCT03390166
Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults No drug interventions prevention 2 / 3 completed NCT03365336
Influenza Management With Polyherbal Formulation treatment Not Available unknown_status NCT03344029
Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years No drug interventions prevention 4 completed NCT03321968
Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults No drug interventions other 3 completed NCT03301051
Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults No drug interventions prevention 3 completed NCT03143101
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age prevention 4 completed NCT03274310
FluSAFE: Flu SMS Alerts to Freeze Exposure No drug interventions prevention Not Available completed NCT03282240
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US No drug interventions prevention 3 completed NCT03239665
Vaccination Education Through Pharmacists and Senior Centers (VEPSC) No drug interventions prevention Not Available completed NCT03058692
Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine No drug interventions prevention 2 completed NCT03104790
Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve Controls prevention 4 completed NCT03101462
Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years No drug interventions prevention 4 completed NCT03088904
Genetic and Environmental Factors in the Response to Influenza Vaccination basic_science 1 completed NCT04579614
Performance Feedback in Health Care No drug interventions health_services_research Not Available completed NCT05035680
Proof of Concept Trial of Adjuvant Activity of SWE, a Squalene-based -Oil-in-water Emulsion No drug interventions prevention 1 withdrawn NCT02819115
Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine No drug interventions Not Available Not Available completed NCT02846311
Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Versus Xpert Flu/RSV No drug interventions Not Available Not Available completed NCT02877160
A Study to Assess the PK of AL-794 Formulations in Healthy Subjects No drug interventions treatment 1 completed NCT02871206
Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite Children Not Available 4 unknown_status NCT02883426
Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease No drug interventions prevention 1 terminated NCT02908269
Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations prevention 4 completed NCT02907580
Influenza Vaccine Attitudes, Intent, and Receipt: Pediatric No drug interventions health_services_research Not Available completed NCT02897011
2-week dc of MTX and Influenza Vaccination in RA treatment Not Available unknown_status NCT02894840
Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults No drug interventions prevention 1 / 2 completed NCT02909842
Effect of Drinking Fermented Milk on Immune Response No drug interventions prevention Not Available completed NCT02915302
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children prevention 4 completed NCT02918006
A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine prevention 2 completed NCT02933723
Immunogenicity of Influenza Vaccine in Long Term Care No drug interventions basic_science Not Available unknown_status NCT02935192
Phase 3 Trial of Serbian Seasonal Influenza Vaccine No drug interventions prevention 3 completed NCT02954354
A Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza treatment 3 completed NCT03023553
The Human Mucosal Immune Responses to Influenza Virus (SLVP026) basic_science 4 completed NCT02907645
Influenza Vaccine Randomized Educational Trial: Adult No drug interventions health_services_research Not Available completed NCT03028987
Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031) basic_science 4 terminated NCT03076385
Safety, Tolerability, and Immunogenicity of VAL-506440 in Healthy Adult Subjects No drug interventions prevention 1 completed NCT03232567
Single-ascending-dose Study of the Safety and Immunogenicity of NasoVAX prevention 2 completed NCT03016143
Immunogenicity and Safety Study of Allantoic Split Inactivated Seasonal Influenza Vaccine (VSI) prevention 2 completed NCT03010410
Platelet Immune Responses in Aging and Influenza and Sepsis (INVACS) No drug interventions Not Available Not Available unknown_status NCT03010007
Prospective Analysis of Seasonal Influenza - Viral Transmission and Evolution in the City of Basel, Switzerland No drug interventions Not Available Not Available completed NCT03020498
B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011) basic_science 4 completed NCT03020537
B-cell Immunity to Influenza (SLVP017)- Year 5, 2013 basic_science 4 completed NCT03020472
Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age basic_science 4 terminated NCT02987374
Pilot Study in Young Adults to Examine the Kinetics of Changes in the B-cell Repertoire Following TIV Immunization basic_science 4 completed NCT02979626
Evaluation of Moderate to Severe Influenza Outcomes in Children No drug interventions Not Available Not Available completed NCT02964065
A Trial on the Efficacy, Safety and Immunogenicity of Live-Attenuated Influenza Vaccine (LAIV) No drug interventions prevention 3 completed NCT02710409
A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older No drug interventions prevention 3 completed NCT02588521
A Study of AL-794 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses, and the Antiviral Activity of Multiple Doses in an Influenza Challenge Study No drug interventions treatment 1 completed NCT02586792
H7N9 Boost in Healthy Adults prevention 2 completed NCT02589574
Improving Influenza Vaccination Rates in Nurses Through Text Message Reminders : a RCT No drug interventions health_services_research Not Available unknown_status NCT02584036
Project IMPACT Immunizations (IMProving America's Communities Together) No drug interventions Not Available Not Available completed NCT02566265
Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients treatment 2 completed NCT02665351
Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections treatment 2 / 3 completed NCT02677493
Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.' No drug interventions treatment 3 completed NCT02522754
Development of an Intranasal Proteosome Influenza Vaccine No drug interventions prevention 1 / 2 completed NCT02554409
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry No drug interventions Not Available Not Available completed NCT02559505
Influenza Immunity in Children No drug interventions basic_science Not Available completed NCT02550197
Immunogenicity and Safety of a Quadrivalent Influenza Vaccine Given by Intramuscular Route in Subjects Aged 18 to 60 Years No drug interventions prevention 3 completed NCT02561169
A Trial of Oseltamivir in High-Risk Patients Presenting to the Emergency Department With Influenza Not Available 4 terminated NCT02553343
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older prevention 2 completed NCT02438423
Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle No drug interventions prevention 1 completed NCT02467842
Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly Subjects No drug interventions prevention 3 completed NCT02609399
ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir treatment 4 completed NCT02603952
A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza treatment 1 / 2 completed NCT02434276
Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years prevention 2 unknown_status NCT02307851
Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults No drug interventions prevention 2 completed NCT02473510
Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season No drug interventions prevention 4 completed NCT02242643
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age prevention 3 completed NCT02423577
Safety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge Strain No drug interventions prevention 2 completed NCT02255409
Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine (QIV) in Children Previously Vaccinated in Trial V118_05 No drug interventions prevention 3 completed NCT02243774
Mail Outreach To Increase Vaccination Acceptance Through Engagement No drug interventions treatment Not Available completed NCT02350751
Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Adults No drug interventions treatment 1 completed NCT02313740
Prospective Cohort Study to Evaluate Safety/Immunogenicity of Butantan Influenza Vaccine in Healthy Adults/Elderly No drug interventions Not Available Not Available completed NCT02352584
A Multicenter, Double-blind, Parallel Phase III Study No drug interventions prevention 3 completed NCT02335164
A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults No drug interventions prevention 1 completed NCT02334514
The Effect of Oseltamivir Treatment on the Yield of Polymerase Chain Reaction Test for Confirmed Influenza Infection No drug interventions Not Available Not Available completed NCT02290509
Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age prevention 3 completed NCT02284594
Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts No drug interventions prevention Not Available completed NCT02263040
A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose TIV prevention 1 / 2 completed NCT02282384
An RCT of Oseltamivir in Outpatients With CPD: A Pilot Study. prevention 4 withdrawn NCT02222870
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine prevention 4 completed NCT02369159
Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza treatment 3 completed NCT02218697
Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older prevention 3 completed NCT02154061
Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics other Not Available completed NCT02151201
Impact of Influenza Vaccination in Pregnancy Video Education No drug interventions prevention Not Available completed NCT02200276
Influenza Immunization in Adults Over Age 75 No drug interventions prevention Not Available recruiting NCT02111252
A Phase 1/2 Study of a Intramuscular Injection of TAK-850 in Healthy Adult Subjects No drug interventions treatment 1 / 2 completed NCT02141581
Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014) basic_science 4 completed NCT02133456
A Post-marketing Safety Study of Inactivated, Split-virion Influenza Vaccine in Subjects Aged 3 Years and Older No drug interventions Not Available Not Available completed NCT02126761
Safety and Immunogenicity of Different Formulations of an Adjuvanted, Trivalent Subunit Influenza Vaccine in Elderly Subjects 65 Years of Age and Above No drug interventions prevention 1 completed NCT02100436
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric Populations No drug interventions prevention 2 completed NCT02107807
Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine No drug interventions prevention 3 completed NCT02045472
A Study of VIS410 to Assess Safety and Pharmacokinetics treatment 1 completed NCT02015494
Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention No drug interventions prevention 1 unknown_status NCT02014168
Safety and Immunogenicity of Co-administration of Candidate Influenza Vaccine MVA-NP+M1 and Viroflu® Seasonal Influenza Vaccine No drug interventions prevention 1 terminated NCT01995851
Randomized Controlled Trial of LAIV vs TIV Vaccines in Schools No drug interventions Not Available Not Available completed NCT02014649
Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza treatment 1 / 2 terminated NCT01990846
Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects No drug interventions treatment 1 completed NCT01998477
A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications No drug interventions prevention 3 completed NCT02019732
Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States No drug interventions Not Available Not Available completed NCT01987349
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009 basic_science 4 completed NCT02008578
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot) No drug interventions treatment 1 completed NCT02000466
FluLaval® Quadrivalent Pregnancy Registry No drug interventions Not Available Not Available withdrawn NCT01999842
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age No drug interventions prevention 1 completed NCT01992094
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older No drug interventions prevention 3 completed NCT01961960
A Study to Evaluate Intramuscular ASP7374 No drug interventions prevention 3 completed NCT01974895
Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age prevention 2 completed NCT01961947
Study of ASP7374, Cell-culture-derived Influenza Vaccine No drug interventions prevention 3 completed NCT01947049
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu No drug interventions diagnostic Not Available completed NCT01967784
Study of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in Taiwan No drug interventions prevention 3 completed NCT01992276
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection treatment 2 withdrawn NCT01938742
H7N9 Mix and Match With MF59 in Healthy Adults No drug interventions prevention 2 completed NCT01938352
Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge No drug interventions treatment 2 completed NCT01938170
Home Administration of FluMist by Parents/Caregivers treatment Not Available completed NCT01959945
Safety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Recombinant Influenza Vaccine,Seasonal Formulation) prevention 3 completed NCT01949090
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older No drug interventions prevention 2 completed NCT01942265
H7N9 Mix and Match With AS03 and MF59 in Healthy Adults No drug interventions prevention 2 completed NCT01891084
The Benefit and Harm of Fever Suppression by Antipyretics in Influenza treatment 4 completed NCT01892631
Text Messaging Reminders for Influenza Vaccine in Primary Care No drug interventions Not Available Not Available completed NCT01859143
Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults No drug interventions prevention 4 completed NCT01842997
Safety of H1N1 Influenza Vaccination in Pregnant Women No drug interventions prevention 4 completed NCT01825200
Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age prevention 3 completed NCT01804946
Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza treatment 4 completed NCT01793883
Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza treatment 2 completed NCT01812980
Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women basic_science 4 completed NCT01797029
A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in Bangladesh No drug interventions prevention 3 completed NCT01816464
Immunogenicity and Safety of Trivalent Influenza Vaccine in Pregnant and Nonpregnant HIV Uninfected Women basic_science 4 completed NCT01819155
Immunogenicity and Safety Trial of Adjuvanted and Non-adjuvanted Trivalent Influenza Vaccine in Tropical Africa prevention 2 completed NCT01788228
Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure prevention 3 completed NCT01779570
Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections No drug interventions treatment 4 completed NCT01756950
Assessment of CR8020, a Monoclonal Antibody Against Influenza A Viruses No drug interventions treatment 1 completed NCT01759654
A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Non-Elderly Adults and Elderly Subjects prevention 3 completed NCT01761799
Protecting Pregnant Women From Infectious Diseases No drug interventions health_services_research Not Available completed NCT01719783
Reactogenicity, Safety, and Immunogenicity of a Live Monovalent H5N2 Influenza Vaccine No drug interventions prevention 1 completed NCT01720277
High Dose Influenza Vaccine in Nursing Home - Pilot Study prevention 4 completed NCT01730378
Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old prevention 4 completed NCT01728090
Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections No drug interventions prevention 4 completed NCT01677689
Study to Investigate the Efficacy and Safety of Apomivir® No drug interventions treatment 2 unknown_status NCT01707602
Routes of Immunization and Flu Immune Responses Not Available 1 / 2 completed NCT01693380
Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza prevention 4 completed NCT01691326
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation) prevention 4 completed NCT01651494
Influenza Antiviral DAS-181-F04 in Healthy Adults treatment 1 completed NCT01680679
Influenza Immunization of Children in India No drug interventions prevention 4 completed NCT01626820
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults prevention 3 completed NCT01662583
Vaccine Health Literacy Related Text Message Reminders to Increase Receipt of Second Dose of Influenza Vaccine for Young, Low Income, Urban Children No drug interventions health_services_research Not Available completed NCT01654809
Safety and Immunogenicity Study of Split Influenza Virus Vaccine in Different Age Groups No drug interventions prevention 4 completed NCT01665807
A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine health_services_research 4 completed NCT01646138
Influenza A 2009 H1N1 Challenge Study in Healthy Adults No drug interventions basic_science 1 / 2 completed NCT01622491
Effectiveness of H1N1 Influenza Vaccines in Manitoba, Canada No drug interventions Not Available Not Available unknown_status NCT01640327
Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults Aged 18 Years and Above No drug interventions prevention 3 completed NCT01607112
A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above prevention 3 completed NCT01612000
Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults No drug interventions prevention 1 / 2 completed NCT01599390
Influenza Burden Assessment in the United States, July1997 - up to April 2009 No drug interventions Not Available Not Available completed NCT01631071
Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains No drug interventions prevention Not Available completed NCT01580033
Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine No drug interventions prevention 3 completed NCT01573312
H5N1 Vaccination With and Without AS03: Systems Biology Analysis prevention 1 completed NCT01561768
A Study to Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults No drug interventions prevention 2 completed NCT01592799
Study on the Burden of Influenza-related Hospitalizations and Emergency Room (ER) Visits in Children in Spain No drug interventions other Not Available completed NCT01551823
The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) （Children Forms of Drug） prevention 3 completed NCT01554826
Clinical Trial of the Inactivated Influenza Vaccine (0.25ml Formulation for Pediatric Use) prevention 3 completed NCT01560793
Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years No drug interventions prevention 1 completed NCT01538940
Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand No drug interventions prevention 4 completed NCT01512056
Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients treatment 4 unknown_status NCT01514708
The Safety and Immune Response to Influenza Vaccination in Pregnant Women prevention 4 completed NCT01507779
Safety Trial of Monovalent Whole Virus Influenza (H1N1) Vaccine No drug interventions prevention 1 completed NCT01457027
A Study to Assess Immunogenicity Parameters After Vaccination Against Influenza and to Evaluate How These Parameters Change During the Influenza Season No drug interventions prevention 4 completed NCT01459276
A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects No drug interventions prevention Not Available completed NCT01455753
The Effect of Proximity on Flu-Shot Participation No drug interventions Not Available Not Available completed NCT01481454
Study of a Quadrivalent Influenza Vaccine Administered Intramuscularly in Children/Adolescents and Adults No drug interventions prevention 3 completed NCT01481467
Evaluation of an Influenza Vaccination Implementation Strategy for Hospital Health Care Workers No drug interventions health_services_research Not Available unknown_status NCT01440387
A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older prevention 3 completed NCT01472536
A Study of Exclusion Criteria in a University Population No drug interventions prevention Not Available completed NCT01431768
Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B No drug interventions diagnostic Not Available completed NCT01436370
TIV and High Dose TIV in Subjects With Rheumatoid Arthritis No drug interventions prevention 2 completed NCT01403649
Collaborative Efforts to Increase Flu Vaccination No drug interventions health_services_research Not Available completed NCT01389479
Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults prevention 3 completed NCT01416571
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults prevention 2 completed NCT01332578
A Comparison of Solid and Soluble Forms of Cold and Influenza Remedies Not Available 4 completed NCT01356342
Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Healthy Subjects Aged Over 6 Months Old to 18 Years Old prevention 4 completed NCT01323946
Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children No drug interventions prevention 2 completed NCT01298102
Influenza A/H1N1/2009-adjuvanted Vaccine in Renal Disease Patients prevention 4 completed NCT01303510
A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Virus Strains for the Northern Hemisphere No drug interventions treatment 4 completed NCT01306682
Influenza Vaccination of HIV Infected Pregnant Women: Safety and Immunogenicity prevention 2 / 3 completed NCT01299142
Safety and Pharmacokinetics Study of Human Monoclonal Antibody (FGI-101-1A6) No drug interventions prevention 1 unknown_status NCT01310400
Comparison of the Efficacy of Inflexal V With a Commercially Available Influenza Vaccine in Young Children No drug interventions treatment 3 completed NCT01313962
Safety Study of Flufirvitide-3 Nasal Spray in Healthy Subjects No drug interventions treatment 1 completed NCT01270685
2009 H1N1 Pandemic and Seasonal Influenza in SCI/D: Infection Control Strategies No drug interventions Not Available Not Available withdrawn NCT01286285
Surveillance of Influenza in Paediatric Intensive Care Units in Bavaria No drug interventions Not Available Not Available unknown_status NCT01246999
Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children treatment 4 completed NCT01271842
Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study No drug interventions Not Available Not Available completed NCT01227798
Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza treatment 1 / 2 unknown_status NCT01258595
A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age prevention 2 completed NCT01240746
Study of Quadrivalent Influenza Vaccine Among Children prevention 3 completed NCT01218308
A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children prevention 3 completed NCT01218646
Study of Quadrivalent Influenza Vaccine Among Adults prevention 3 completed NCT01195038
Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed Adults No drug interventions prevention 2 completed NCT01224262
A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001 prevention 1 / 2 completed NCT01222403
A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older No drug interventions prevention 4 completed NCT01224795
A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza. treatment 3 terminated NCT01202552
Two-site Intradermal Influenza Vaccination in Elderly No drug interventions prevention Not Available completed NCT01198756
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children prevention 3 completed NCT01173211
2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women No drug interventions prevention 2 completed NCT01182870
Vitamin D and the Influenza Epidemic No drug interventions prevention 3 completed NCT01194297
Study of Live, Attenuated Influenza Vaccination in Preterm and Full-Term Infants prevention 4 terminated NCT01191853
Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines No drug interventions Not Available Not Available completed NCT01153685
Immunogenicity & Safety Study of Fluviral® (2010 - 2011 Season) in Adults Aged 18 to 60 Years and Over 60 Years prevention 3 completed NCT01171157
Effectiveness of Flu Vaccination and Burden of Illness Among Community-dwelling Elderly With Influenza Like Illness in Brazil No drug interventions Not Available Not Available terminated NCT01172054
Comparative Safety and Immunogenicity of VAX128A, VAC128B and VAX128C Novel H1N1 Influenza Vaccine in Healthy Adults No drug interventions prevention 1 completed NCT01146912
TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations No drug interventions health_services_research Not Available completed NCT01146015
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2010/2011 Season prevention 3 completed NCT01147068
Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults No drug interventions prevention 1 / 2 completed NCT01161160
Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old No drug interventions prevention 2 completed NCT01164553
Comparison of Flu Vaccine Doses in Children No drug interventions prevention 1 completed NCT01138397
Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route) No drug interventions prevention 3 completed NCT01150149
Evaluating Modes of Influenza Transmission Between Humans No drug interventions prevention Not Available withdrawn NCT01086566
Cellular and Humoral Immune Response to Primary and Secondary Immunization With Subvirion H5N1 Vaccines No drug interventions prevention 1 completed NCT01130636
Observational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza During Lactation basic_science 4 completed NCT01083511
Collection and Extraction of Respiratory Specimens No drug interventions Not Available Not Available completed NCT01096238
Follow-up of Immunogenicity of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Healthy Volunteers After 6 Months No drug interventions Not Available Not Available unknown_status NCT01096056
Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children prevention 1 completed NCT01089660
A Study of the Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults No drug interventions prevention 2 completed NCT01068912
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza treatment 2 completed NCT01078779
The Chloroquine for Influenza Prevention Trial prevention 2 unknown_status NCT01011049
Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM prevention 2 completed NCT01014091
Study to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in Children No drug interventions prevention 3 terminated NCT01053143
Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India No drug interventions prevention 3 completed NCT01052961
A Study on Higher-dose Oseltamivir Treatment's Impact on Viral Clearance and Clinical Recovery in Adults Hospitalized With Influenza treatment 4 completed NCT01051661
Safety and Efficacy of H1N1 Vaccines in Children Aged 6 Months to Less Than 10 Years of Age No drug interventions prevention 3 completed NCT01050465
MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use No drug interventions Not Available Not Available completed NCT01045564
Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure No drug interventions prevention 2 withdrawn NCT01010737
A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Injected to Elderly Volunteers prevention 1 / 2 completed NCT01055990
Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients No drug interventions treatment 2 unknown_status NCT01046331
Novel Influenza A (H1N1) Surveillance Registry No drug interventions Not Available Not Available completed NCT00996138
Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects No drug interventions prevention 2 / 3 completed NCT01023776
Infectivity, Replication & Immunogenicity of Live nH1N1 Vaccine prevention 4 completed NCT01032837
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu Strain treatment 4 terminated NCT01007201
Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric Population prevention Not Available completed NCT01033799
Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers No drug interventions basic_science Not Available completed NCT01026350
Safety and Efficacy of Oral Colostrum Derived Anti Influenza Antibodies in Healthy Volunteers No drug interventions prevention 1 unknown_status NCT00996307
Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months No drug interventions prevention 2 / 3 completed NCT00992784
Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People No drug interventions prevention 3 completed NCT00956202
A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years No drug interventions prevention 2 completed NCT01008956
Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults No drug interventions prevention 2 withdrawn NCT00993083
A Study to Assess the Safety and Efficacy of a New Influenza Candidate Vaccine MVA-NP+M1 In Healthy Adults No drug interventions prevention 2 completed NCT00992511
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing Processes No drug interventions prevention 3 completed NCT00958243
A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA No drug interventions prevention 2 completed NCT01006798
Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1 No drug interventions prevention 1 completed NCT00976820
Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age No drug interventions prevention 2 completed NCT00975884
Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults No drug interventions prevention 3 completed NCT00999206
Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived Influenza Vaccine No drug interventions prevention 3 completed NCT01004653
A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines prevention 4 completed NCT01008137
Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults prevention 4 completed NCT00996853
Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom No drug interventions Not Available Not Available completed NCT00989287
Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults No drug interventions prevention 3 completed NCT01001169
Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children No drug interventions prevention 2 completed NCT00979251
Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects treatment 2 completed NCT00979407
Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1) No drug interventions prevention 3 completed NCT00980005
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children prevention 3 completed NCT00980109
Long Term Influenza Prophylaxis With Inhaled Zanamivir or Oral Oseltamivir prevention 4 completed NCT00985088
Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older No drug interventions prevention 2 completed NCT00938392
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly No drug interventions prevention 3 completed NCT00968890
Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly prevention 2 completed NCT00966342
Rapid Evaluation of Seasonal Influenza Vaccine prevention 1 withdrawn NCT00965354
Mechanisms of Severe Acute Influenza Consortium (MOSAIC) No drug interventions Not Available Not Available completed NCT00921206
Study to Investigate the Immune Response to Two Doses of VAX102 Healthy Adults No drug interventions prevention 1 completed NCT00921973
Safety of VAX102 Vaccine Given With Seasonal Flu Vaccine in Healthy Adults No drug interventions prevention 1 completed NCT00968526
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults No drug interventions prevention 3 completed NCT00966238
Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of Age No drug interventions prevention 2 completed NCT00950456
Observational Study to Assess Safety of H1N1 Pandemic Influenza Vaccine No drug interventions Not Available Not Available completed NCT00970606
STIP: Statin Trial for Influenza Patients treatment Not Available terminated NCT00946101
A Study to Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age prevention 4 completed NCT00949533
A Study on Emergence of Resistance With Oseltamivir (Tamiflu) in Participants With Seasonal Influenza treatment 3 completed NCT00944073
Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels No drug interventions prevention 2 completed NCT00935194
Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study treatment 4 completed NCT00936468
Safety, Tolerability and Immunogenicity of Fluzone® With and Without JVRS-100 in Elderly Subjects prevention 2 completed NCT00885105
Evaluation of Responses to Fluzone® in Infants ≥ 6 Months of Age Who Did or Did Not Receive Fluzone® at 2 Months of Age prevention 3 completed NCT00889889
Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus Revaccination No drug interventions prevention 2 completed NCT00900588
Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents No drug interventions prevention 2 completed NCT00858468
Safety and Immunogenicity Testing of Influenza Vaccine in Healthy Children 2 Months and 6 Months of Age prevention 1 / 2 completed NCT00881842
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 09/10 Season prevention 3 completed NCT00848887
A Dose Ranging Study Comparing Different Combinations of Adjuvanted and Non-adjuvanted Influenza Vaccines in Healthy Children 6 to <36 Months of Age No drug interventions prevention 1 completed NCT00836953
Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone® prevention 4 completed NCT00831987
Safety and Immunogenicity of the World Health Organization (WHO) Formulation of the 2004-2005 Fluzone® Vaccine prevention 4 completed NCT00825162
Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Years No drug interventions prevention 4 completed NCT00814385
Immunogenicity of Adjuvanted or Non-adjuvanted H5N1 Booster Vaccine in Adults Primed to A/VN/1194/04 Not Available 1 / 2 completed NCT00831675
Study of Safety and Immunogenicity of Fluzone® in Healthy Children prevention 4 completed NCT00828100
Comparison of Fluid Rapid Influenza and BinaxNOW Influenza A & B No drug interventions diagnostic 3 suspended NCT00812110
Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home prevention 4 completed NCT00844051
Study to Evaluate Impact of School-based Influenza Vaccination on School Populations No drug interventions prevention Not Available completed NCT00817661
Vitamin A and Maternal-infant Flu Vaccine Response No drug interventions prevention Not Available completed NCT00822627
Influenza Vaccination in the Emergency Department No drug interventions health_services_research Not Available completed NCT00735475
A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine prevention 4 completed NCT00771615
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years No drug interventions prevention 2 completed NCT00798421
Study to Evaluate Nosocomial Transmission of Influenza No drug interventions Not Available Not Available unknown_status NCT00778895
Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control prevention 2 completed NCT00778297
Immunogenicity and Tolerability Study of FluvalAB FL-K-004 Trivalent Influenza Vaccine No drug interventions prevention Not Available completed NCT00772109
Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults prevention 3 completed NCT00772889
Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly prevention 3 completed NCT00783926
Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant) No drug interventions prevention 1 completed NCT00755274
Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone® prevention 4 completed NCT00758212
Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem treatment Not Available unknown_status NCT00757900
Efficacy of Influenza Vaccine in HIV Infected Adults No drug interventions prevention 4 completed NCT00756574
Randomized Control Trial to Study the Efficacy of the Surgical Mask Versus the N95 Respirator to Prevent Influenza No drug interventions prevention Not Available completed NCT00764998
Influenza Vaccine in HIV prevention 3 completed NCT00742885
Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine prevention 2 completed NCT00735020
Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines No drug interventions prevention 1 completed NCT00722774
Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine No drug interventions prevention 1 completed NCT00662272
Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant prevention 1 completed NCT00703651
Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults prevention 2 completed NCT00709800
Pandemic Influenza Plasmid DNA Vaccines (Needle) No drug interventions prevention 1 completed NCT00706732
A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza No drug interventions prevention 1 / 2 completed NCT00711295
Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups No drug interventions prevention 3 completed NCT00710866
Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity prevention 3 completed NCT00633074
Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations prevention 2 completed NCT00623181
Study to Determine a Preference for Fluzone Vaccine Given Intradermally (ID) and Intramuscularly (IM) in Healthy Adults prevention 2 completed NCT00693706
Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix prevention 1 completed NCT00677820
A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine No drug interventions prevention 4 completed NCT00665509
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 08/09 Season. prevention 3 completed NCT00616928
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years prevention 3 completed NCT00606359
Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant Subjects prevention 2 completed NCT00646152
Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study treatment 1 completed NCT00652743
Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules No drug interventions prevention 3 completed NCT00657111
CS-8958 Single Inhaled Dose in Elderly treatment 1 completed NCT00649883
Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months No drug interventions prevention 2 completed NCT00630331
Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects No drug interventions prevention 3 completed NCT00613184
Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses No drug interventions diagnostic Not Available unknown_status NCT00617331
H9 Priming Study in Healthy Adults prevention 2 completed NCT00593502
Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age prevention 4 completed NCT00555893
Efficacy Study of Early Versus Late Oseltamivir Administration for Treating and Preventing Influenza treatment Not Available completed NCT00562484
A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults No drug interventions prevention 4 completed NCT00570037
Feasibility of Cocooning Immunization Strategy With Influenza Vaccine prevention Not Available completed NCT00518726
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects No drug interventions prevention 2 completed NCT00539864
Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV prevention 3 completed NCT00551031
Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects prevention 2 completed NCT00554333
Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM Vaccine No drug interventions prevention 3 completed NCT00556062
Phase IV Clinical Trial of an Influenza Split Vaccine Anflu No drug interventions prevention 4 completed NCT00518453
Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008 No drug interventions prevention 2 completed NCT00539981
Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok prevention 3 completed NCT00502593
Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Children prevention 2 completed NCT00538512
Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4 prevention 4 completed NCT00514709
Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants prevention 3 completed NCT00486980
Intramuscular Peramivir for the Treatment of Uncomplicated Influenza Not Available 3 withdrawn NCT00522236
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects No drug interventions prevention 2 completed NCT00506350
Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults No drug interventions prevention 2 completed NCT00527865
Single Dose Escalating Study of DAS181 in Adults treatment 1 completed NCT00504231
Intradermal Influenza Vaccine Study in Elders prevention 2 completed NCT00505453
A Phase III, Open-Label, Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral® Vaccine prevention 3 completed NCT00490633
Intervention Study of Face Mask and Hand Sanitizer to Reduce Influenza Transmission No drug interventions prevention Not Available completed NCT00464672
Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old No drug interventions prevention 3 completed NCT00491283
QuickVue Influenza A+B Clinical Field Trial No drug interventions diagnostic Not Available completed NCT00476307
Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above prevention 3 completed NCT00455169
Influenza Vaccine in Premature Infants No drug interventions Not Available Not Available completed NCT00442975
Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus (CMV) Status prevention 4 completed NCT00428493
Prospective Study of AI H5N1 in China No drug interventions Not Available Not Available completed NCT00428753
China Case Control Avian Influenza No drug interventions Not Available Not Available completed NCT00421837
Pilot Study of Genotypic Analysis No drug interventions Not Available Not Available completed NCT00389532
Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine prevention 4 completed NCT00401700
Influenza Vaccine Postpartum Questionnaire No drug interventions Not Available Not Available completed NCT00408395
Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children No drug interventions prevention 2 completed NCT00404664
Improving Influenza Vaccination Rates Among Health Care Professionals No drug interventions educational_counseling_training Not Available completed NCT00410176
A Randomized, Controlled, Unblinded, Clinical Trial of the Acceptability and Efficacy of Non-Pharmaceutical Methods in Preventing Spread of Influenza Within the Family No drug interventions prevention Not Available unknown_status NCT00386698
Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly Adults prevention 2 completed NCT00370864
Study of a Pandemic Influenza Vaccine in Children No drug interventions prevention 2 completed NCT00391768
Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza treatment 1 / 2 completed NCT00386542
Needle-free Jet Injection of Reduced-dose, Intradermal, Influenza Vaccine in >= 6 to < 24-month-old Children prevention 1 / 2 completed NCT00395174
Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults prevention 3 completed NCT00396305
Th1 Response to Influenza: Aging and Vaccine Efficacy No drug interventions prevention 4 terminated NCT00391053
Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly prevention 3 completed NCT00390884
Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation. prevention 4 completed NCT00383123
Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children prevention 3 completed NCT00397215
Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Adults Over 60 Years of Age prevention 2 completed NCT00382980
Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults prevention 1 completed NCT00391391
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children prevention 2 completed NCT00383526
Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly prevention 3 completed NCT00380237
Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B) No drug interventions prevention 1 completed NCT00376402
Study of a Pandemic Influenza Vaccine in Elderly Participants No drug interventions prevention 2 completed NCT00380211
Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults prevention 3 completed NCT00377585
Demonstrate the Superiority of the Immune Response of Adjuvanted Influenza Vaccine Induced in an Adult Population prevention 2 completed NCT00375206
A Safety and Immunology Study of a DNA Trivalent Influenza Vaccine No drug interventions prevention 1 completed NCT00374842
Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate prevention 2 completed NCT00334529
Alternative Oseltamivir Dosing Strategies prevention 2 completed NCT00375115
Efficacy of Sambucol in the Treatment of Influenza No drug interventions treatment 4 completed NCT00363077
Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate prevention 2 completed NCT00356798
Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects No drug interventions prevention 1 completed NCT00348881
Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants No drug interventions prevention 3 completed NCT00298233
High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza treatment 2 completed NCT00296829
Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly No drug interventions prevention 2 completed NCT00306995
Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population No drug interventions prevention 2 completed NCT00306982
Incidence of Influenza, Downstream Complications of Influenza & Hospitalizations in Elderly Vaccinated With Fluarix™ Not Available Not Available completed NCT00318149
Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly Population prevention 2 completed NCT00328107
Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults prevention 2 / 3 completed NCT00307177
Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma No drug interventions prevention 2 completed NCT00306943
Annual Study for Fluarix Registration No drug interventions prevention 3 completed NCT00306527
Comparison of Safety, Tolerability and Immunogenicity of Influenza Vaccines in Adults and Elderly No drug interventions prevention 3 completed NCT00283283
Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine prevention 2 completed NCT00311428
Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months No drug interventions prevention 4 completed NCT00311675
St. Jude Open Label H5 Trial prevention 1 / 2 completed NCT00263900
TGV:Use of the Quick Diagnostic Test of the Influenza and the Infection With RSV by the Paediatric Emergency Unit No drug interventions diagnostic Not Available completed NCT00240877
Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024) No drug interventions prevention 3 completed NCT00216242
Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o. educational_counseling_training 3 unknown_status NCT00213967
The Effect of Needle Temperature on Pain Ratings Following Intramuscular Injection No drug interventions Not Available Not Available completed NCT00232947
Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over educational_counseling_training 3 completed NCT00192231
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T) No drug interventions prevention 3 completed NCT00205270
Influenza Vaccine in Lung Transplant Patients No drug interventions Not Available Not Available completed NCT00192361
Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0) No drug interventions prevention 3 completed NCT00192127
Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults prevention 3 completed NCT00192491
Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children prevention 3 completed NCT00197223
Post-marketing Study to Evaluate the Efficacy of Influenza Vaccine No drug interventions prevention 3 completed NCT00170482
Elderly Influenza Vaccine Immunogenicity Substudy No drug interventions Not Available Not Available completed NCT00170547
Comparison of Delivery Routes of Flu Vaccine in Adults No drug interventions prevention 2 completed NCT00192426
Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children. No drug interventions prevention 3 completed NCT00137579
Safety of the Intramuscular Route of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation Therapy No drug interventions treatment 4 completed NCT00136331
Study of a Pandemic Influenza Vaccine No drug interventions prevention 1 completed NCT00133588
Proteomic Profiling for Influenza No drug interventions prevention 4 completed NCT00133471
Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults prevention 1 / 2 completed NCT00133536
A/H5N1 Vaccine in Healthy Children Aged 2-9 Years prevention 1 / 2 completed NCT00138281
Influenza Immunity Against Pandemic Respiratory Virus prevention 4 completed NCT00125944
Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults Not Available 3 completed NCT00138385
Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment prevention 4 completed NCT00100399
Fluarix Immunogenicity and Safety Trial prevention 3 completed NCT00110279
Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A) No drug interventions prevention 1 completed NCT00006146
Half-Dose Flu Vaccine Study in Healthy Adults No drug interventions prevention 2 completed NCT00001127
Study of a Flu Vaccine in Children No drug interventions prevention 3 completed NCT06528444
Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza treatment 3 withdrawn NCT06506812
Pooled Analysis of Methodologically Harmonized Pragmatic Randomized Trials of High-Dose vs. Standard-Dose Influenza Vaccine Against Severe Clinical Outcomes No drug interventions treatment 4 not_yet_recruiting NCT06417762
Dime La VerDAD: Verify, Debunk, and Disseminate No drug interventions prevention Not Available recruiting NCT06207058
Evaluation of a Screen and Treat Protocol for Influenza Not Available Not Available not_yet_recruiting NCT06183229
Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza prevention 3 recruiting NCT06179446
A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza No drug interventions prevention 1 recruiting NCT06168019
Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India No drug interventions Not Available Not Available recruiting NCT06141655
HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia No drug interventions prevention 4 recruiting NCT06052527
Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning No drug interventions Not Available Not Available completed NCT06054269
Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP prevention 3 active_not_recruiting NCT06091410
Immunogenicity of Concomitant Administration of COVID-19 Vaccines With Influenza Vaccines No drug interventions basic_science 4 active_not_recruiting NCT06103994
Study to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination No drug interventions treatment Not Available completed NCT06094010
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Participants With Influenza treatment 3 recruiting NCT06097273
A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age No drug interventions prevention 3 completed NCT06030726
Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Older Adults No drug interventions other Not Available active_not_recruiting NCT06020118
Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations No drug interventions prevention 4 completed NCT06030739
Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake Among Adults With Chronic Disease No drug interventions other Not Available active_not_recruiting NCT05968989
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults No drug interventions prevention 1 recruiting NCT05827926
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults No drug interventions prevention 1 / 2 active_not_recruiting NCT05525494
Patient Portal Flu Vaccine Reminders (5) No drug interventions health_services_research Not Available completed NCT05523089
The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults No drug interventions prevention 2 completed NCT05375838
A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old treatment 1 / 2 completed NCT05315024
Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive Children prevention Not Available unknown_status NCT05353725
Extracorporeal Membrane Oxygenation in Coronavirus Disease (COVID-19), Influenza and ARDS of Other Ethiologies No drug interventions Not Available Not Available completed NCT05297994
Trial of the Reactogenicity, Safety and Immunogenicity of the Flu-M Vaccine Manufactured by FSUE SPbSRIVS FMBA No drug interventions prevention 2 completed NCT05291676
Systems Investigation of Vaccine Responses in Aging and Frailty prevention 2 recruiting NCT05266222
Respiratory Virus Sampling and Repository No drug interventions Not Available Not Available recruiting NCT05045612
Antibiotic Therapy in Viral Airway Infections No drug interventions treatment 4 recruiting NCT04941092
Comparison of ARDS COVID-19 (WHO) vs ARDS Influenza in the ICU No drug interventions Not Available Not Available completed NCT05734040
Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects. prevention 2 completed NCT04912180
Apple Respiratory Study No drug interventions Not Available Not Available terminated NCT04896086
First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV, in Healthy Adults prevention 1 completed NCT04794829
Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination No drug interventions Not Available Not Available recruiting NCT04736758
A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza No drug interventions treatment 2 completed NCT04663776
Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study Platform No drug interventions Not Available Not Available completed NCT04668417
Pediatric Second Influenza Dose Portal Reminder Recall No drug interventions health_services_research Not Available completed NCT04603989
A Study of HNC042 in Healthy Chinese Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics No drug interventions treatment 1 completed NCT04544267
Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age No drug interventions prevention 3 suspended NCT04531657
Influenza Vaccine in Lung Transplant Patients - Seroprotection No drug interventions Not Available Not Available completed NCT04533139
Influenza Vaccine in Lung Transplant Patients - Antibody No drug interventions Not Available Not Available completed NCT04530786
Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season No drug interventions Not Available Not Available completed NCT04523324
Immunogenicity Trial of Recombinant Influenza Vaccine Among HCP in Israel basic_science 4 completed NCT04377165
Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care Facilities No drug interventions prevention Not Available terminated NCT04365608
Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment No drug interventions treatment Not Available completed NCT04297462
Different Regimens in Influenza Postexposure Chemoprophylaxis in Children prevention Not Available unknown_status NCT04223544
Incidence of Influenza Infections and Determination of Vaccination Coverage Rate Among Healthcare Workers No drug interventions Not Available Not Available unknown_status NCT04164212
Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection treatment 4 suspended NCT04146623
Safety Study of Live Attenuated Influenza Vaccine, CodaVax, Delivered Via Intranasal Spray No drug interventions prevention 1 completed NCT04131296
Lung Bacteriobiota and Influenza Mortality No drug interventions Not Available Not Available unknown_status NCT04109222
Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively other 4 completed NCT04101838
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults basic_science 4 recruiting NCT04110314
Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- RCT 2 No drug interventions health_services_research Not Available completed NCT04106817
Single Ascending Dose Challenge Study to Determine Safety and Reactogenicity of an Influenza Challenge Virus No drug interventions basic_science 1 completed NCT03965195
Recombinant Influenza Vaccination in U.S. Nursing Homes prevention 4 active_not_recruiting NCT03950986
Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System No drug interventions prevention Not Available completed NCT03930017
Pregnancy, Arsenic and Immune Response Not Available Not Available completed NCT03926416
Safety Study of Live Attenuated Influenza Vaccine, CodaVax prevention 1 completed NCT03898986
The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets basic_science 1 completed NCT03901001
Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of Influenza treatment 3 recruiting NCT03884296
Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood basic_science 4 withdrawn NCT03849560
Safety, Reactogenicity, Immunogenicity, and Efficacy of Quadrivalent Inactivated Subunit Influenza Vaccine Grippol® Quadri and Trivalent Inactivated Polymer-Subunit Vaccine Grippol® Plus in Volunteers No drug interventions prevention 2 / 3 completed NCT03845231
Mucosal and Systemic Immunity After Viral Challenge of Healthy Volunteers Vaccinated With Inactivated Influenza Vaccine Via the Intranasal Versus Intramuscular Route basic_science 2 completed NCT03757546
Extra-pulmonary Clinical Manifestations of Influenza Virus and Respiratory Syncitial Virus Infections No drug interventions Not Available Not Available completed NCT03777163
Safety and Immunogenicity of the Butantan Institute Influenza Vaccine Compared to Sanofi Pasteur Influenza Vaccine No drug interventions prevention 4 completed NCT03744104
A Clinical Trial of A Quadrivalent Influenza Vaccine No drug interventions prevention 3 completed NCT03718468
A Study to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine prevention 3 completed NCT03694392
Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years Not Available Not Available completed NCT03669627
CT18 Infant Influenza Priming Study in Vaccine Naive Infants prevention 2 completed NCT03617523
Safety and Immunogenicity of Fluzone® Quadrivalent, Flublok® Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2018-2019 Formulations prevention 4 completed NCT03598439
Randomized Influenza Vaccine Evaluation of Immune Response basic_science 4 active_not_recruiting NCT03595358
Ellume·Lab Flu A+B Test and the Ellume Home Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction No drug interventions diagnostic Not Available completed NCT03590808
Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor No drug interventions prevention Not Available completed NCT03564444
D2560C00015 FluMist Annual Safety Study 2018 No drug interventions prevention 4 completed NCT03553940
H3N2 M2SR in Pediatric Population No drug interventions prevention 1 completed NCT03546192
Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route) prevention 4 completed NCT04622592
Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older No drug interventions other 1 / 2 completed NCT04695717
This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam No drug interventions prevention 3 completed NCT05582239
Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults No drug interventions Not Available Not Available recruiting NCT05569239
Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg No drug interventions prevention 2 not_yet_recruiting NCT05519839
A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine prevention 2 completed NCT05212623
A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months No drug interventions prevention 1 completed NCT05215327
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients prevention 2 recruiting NCT05537441
Precision Vaccine Promotion in Underserved Populations No drug interventions prevention Not Available completed NCT05544916
A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections treatment 3 completed NCT05542004
Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake No drug interventions other Not Available completed NCT05868382
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults No drug interventions prevention 2 completed NCT05869201
Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine No drug interventions prevention 2 / 3 completed NCT05739474
Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children No drug interventions prevention 3 recruiting NCT03139565
High Dose vs. Standard Influenza Vaccine in Adult SOT prevention 3 completed NCT03459391
Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers treatment 1 completed NCT03455491
Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections treatment 2 completed NCT03441373
XC8 in the Treatment of Patients With Acute Respiratory Viral Infection treatment 2 / 3 completed NCT03430089
Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza Vaccine No drug interventions prevention 1 completed NCT03437304
Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU in Older Adults No drug interventions prevention 1 / 2 completed NCT03372967
Project IMPACT Immunizations (IMProving America's Communities Together) Scaled Demonstration No drug interventions Not Available Not Available completed NCT06124131
Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening No drug interventions screening Not Available completed NCT03331991
Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel No drug interventions Not Available Not Available completed NCT03323112
Immune Responses in Health Care Personnel No drug interventions Not Available Not Available recruiting NCT03308825
Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines prevention 4 completed NCT03300050
Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine No drug interventions prevention 1 completed NCT03300362
Improved Novel VaccIne CombinaTion InflUenza Study prevention 2 terminated NCT06125717
Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP No drug interventions prevention 1 completed NCT04579250
Dose, Safety, Tolerability and Immunogenicity of an Influenza H10 Stabilized Stem Ferritin Vaccine, VRC-FLUNPF0103-00-VP, in Healthy Adults No drug interventions prevention 1 completed NCT02743676
A Retrospective, Observational Registry of Participants With Avian Influenza Infection No drug interventions Not Available Not Available completed NCT02743117
Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 Season No drug interventions prevention 4 completed NCT02819180
Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine - FLU-02-IB No drug interventions Not Available Not Available completed NCT02868658
Asymptomatic Flu Project No drug interventions prevention Not Available completed NCT02955030
Evaluation of the Safety and Immunogenicity of a Sublingual Influenza Vaccine NSV0001 in Healthy Male Volunteers No drug interventions prevention 1 completed NCT02983019
Treatment of Influenza in Routine Clinical Practice No drug interventions Not Available Not Available completed NCT03022396
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010 basic_science 4 completed NCT03022422
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011 basic_science 4 completed NCT03023176
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 5, 2013 basic_science 4 completed NCT03028974
Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029) basic_science 4 completed NCT03035396
Clinical Performance of the Diassess Influenza A and B Test No drug interventions device_feasibility Not Available completed NCT03061955
Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab) No drug interventions Not Available Not Available completed NCT03231995
Biomarkers for the Prognosis of Influenza in Children No drug interventions other Not Available completed NCT02989194
Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A treatment 2 completed NCT03004040
Protection From Influenza: Determining the Impact of Prior Infection No drug interventions Not Available Not Available unknown_status NCT02972957
A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia prevention 4 completed NCT02979730
Impact of Rapid Flu Testing in BMC ED No drug interventions diagnostic Not Available completed NCT02962908
A Randomised, Double-blind, Placebo-controlled Phase IIb Trial to Test FLU-v Vaccine No drug interventions prevention 2 completed NCT02691130
Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults No drug interventions prevention 2 completed NCT02525055
Characterisation of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model No drug interventions basic_science Not Available completed NCT02662426
Lingdancao Granules in the Treatment of Seasonal Influenza treatment 3 unknown_status NCT02529904
ADITEC FLU 2 STUDY: Understanding the Genetics Basis for Immune Responses to Flu Vaccines in Children and Adults prevention 2 completed NCT02539108
Safety and Immunogenicity of the 2015-2016 Formulation of Fluzone® Quadrivalent (Influenza Vaccine) Among Healthy Children prevention 4 completed NCT02485639
Analysis of Bone Marrow and Blood B Cell Immune Responses to Influenza Vaccination No drug interventions prevention 4 terminated NCT02480101
Reactogenicity, Safety and Immunogenicity of a LAIV H7N9 Influenza Vaccine No drug interventions prevention 1 completed NCT02385123
Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers No drug interventions prevention 4 terminated NCT02640989
Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military prevention 4 completed NCT02635724
Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated Influenza treatment 3 completed NCT02247362
Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years No drug interventions prevention 1 / 2 unknown_status NCT02302924
Evaluation of Psychometric Testing Properties of Severity Symptom Grading Scale of Influenza Infection: Flu-PRO Stage III No drug interventions Not Available Not Available completed NCT02263027
Do Some Healthy Adults Consistently Have Systemic Reactions to Influenza Vaccines? No drug interventions prevention 4 completed NCT02369341
Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above prevention 3 completed NCT02362919
Influenza Vaccination Among the Elderly Individuals No drug interventions Not Available Not Available completed NCT02366962
A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older No drug interventions prevention 3 completed NCT02228980
Study of a Single Dose or Two Doses of a Trivalent Inactivated Influenza Vaccine Produced at Shenzhen, China No drug interventions prevention 4 completed NCT02207413
A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children prevention 3 completed NCT02177734
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age No drug interventions prevention 1 withdrawn NCT02133781
B-cell Immunity to Influenza (SLVP017)- Year 1, 2009 basic_science 4 completed NCT02121782
A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine) No drug interventions prevention 1 / 2 completed NCT02069496
Drug Use Investigation for Arepanrix® (H1N1) No drug interventions Not Available Not Available completed NCT02056340
Statin Therapy in Acute Influenza treatment 2 completed NCT02037282
A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects No drug interventions treatment 1 withdrawn NCT02062281
Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults No drug interventions prevention 4 completed NCT02008344
Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults treatment 3 completed NCT01985620
The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate. No drug interventions prevention Not Available unknown_status NCT01971255
Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People No drug interventions basic_science 1 / 2 completed NCT01946438
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in Adults prevention 4 completed NCT01946425
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine prevention 4 completed NCT01982331
Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/CALIFORNIA/66/395 (H2N2) Influenza Vaccine No drug interventions prevention 1 completed NCT01984125
Testing the Use of Prompts to Increase Adolescent Immunization Rates No drug interventions health_services_research Not Available completed NCT01934127
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age No drug interventions prevention 1 completed NCT01878812
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older prevention 3 completed NCT01839760
Evaluation of Viral Shedding Patterns and Clinical Outcomes of Influenza Patients No drug interventions Not Available Not Available completed NCT01827462
Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017) prevention 4 completed NCT01850446
Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza treatment 4 completed NCT01811823
Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults basic_science 4 completed NCT01815268
High-Dose Influenza Vaccine in Nursing Homes prevention 4 unknown_status NCT01788514
Combining Entertainment & Influenza Education for Pediatric Patients No drug interventions other Not Available completed NCT01772901
Brief Influenza Vaccine Education to Pregnant Women No drug interventions treatment Not Available completed NCT01719874
Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza No drug interventions treatment 2 unknown_status NCT01761734
Pilot Text Message for Influenza Vaccination No drug interventions health_services_research Not Available completed NCT01752881
Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects prevention 4 completed NCT01767896
Phase-3 Study of ASP7374, Cell-culture-derived Influenza Vaccine No drug interventions prevention 3 completed NCT01746082
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations prevention 2 completed NCT01682369
ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses other 2 completed NCT01720329
Use of Probiotics to Prevent Influenza No drug interventions prevention Not Available completed NCT01715792
Assess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in UK No drug interventions Not Available Not Available completed NCT01683630
Comparison of Epidemiology and Clinical Outcomes of Influenza A & B Cases in Manitoba, Canada No drug interventions Not Available Not Available completed NCT01691339
Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults. prevention 4 completed NCT01625689
Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine No drug interventions prevention 2 completed NCT01651663
A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold treatment 4 unknown_status NCT01623518
A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine ChAdOx1-NP+M1 No drug interventions Not Available 1 completed NCT01654224
Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting No drug interventions prevention 4 completed NCT01640314
Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above No drug interventions prevention 3 completed NCT01631110
Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains No drug interventions prevention 3 completed NCT01551810
The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) prevention 3 completed NCT01584908
Adjuvanted Influenza Vaccine Evaluation in Kidney Transplant Recipients No drug interventions Not Available Not Available completed NCT01578317
Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant No drug interventions prevention 1 / 2 completed NCT01546935
Oseltamivir for Influenza Lower Respiratory Tract Infection in Children Under One treatment 2 / 3 withdrawn NCT01527825
Immunogenicity and Safety of Different Dosing Schedules of Trivalent Influenza Vaccine in HIV-infected Pregnant Women prevention 3 completed NCT01517191
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults No drug interventions Not Available Not Available completed NCT01511419
Safety Trial of Live Attenuated Influenza (H7N3) Vaccine No drug interventions prevention 1 completed NCT01494740
Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants No drug interventions prevention 2 completed NCT01498718
Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV Alone No drug interventions prevention 1 completed NCT01439360
An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children prevention 3 completed NCT01422512
Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects prevention 3 completed NCT01444482
Study of Parenterally Administrated Adjuvanted Seasonal Influenza Vaccine in Healthy Elderly Volunteers basic_science 1 unknown_status NCT01432340
Seasonal Influenza Vaccine Effectiveness Study in Kenya Not Available Not Available unknown_status NCT01430689
Maternal Flu Vaccine Trial in Bamako, Mali prevention 4 completed NCT01406418
Assessment of CR6261, a Monoclonal Antibody Against the Influenza A Virus treatment 1 completed NCT01404182
Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons No drug interventions prevention 4 completed NCT01389466
Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers No drug interventions prevention 1 / 2 completed NCT01419925
A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers No drug interventions prevention 2 completed NCT01412281
Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers No drug interventions prevention 3 completed NCT01356316
Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Non-Elderly Adult and Elderly Subjects prevention 4 completed NCT01357265
Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects No drug interventions prevention 2 completed NCT01336166
The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine No drug interventions prevention 2 completed NCT01355172
Immunogenicity and Safety of AdimFlu-S, Formulation 2010-2011, in Infants Aged Between 6-12months Old prevention 4 completed NCT01317758
H5N1 Mix and Match With AS03 No drug interventions prevention 1 completed NCT01318876
Surveillance for Adverse Events Following Influenza Immunization No drug interventions Not Available Not Available completed NCT01320696
Reverse Genetic H9N2 Influenza Vaccine Study in Adults No drug interventions prevention 1 / 2 completed NCT01306669
Influenza Vaccine Trial in HIV Uninfected Pregnant Women prevention 3 completed NCT01309568
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study" No drug interventions Not Available Not Available completed NCT01304563
2010/2011 Trivalent Influenza Vaccination No drug interventions treatment Not Available completed NCT01265914
A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine No drug interventions prevention 1 completed NCT01236040
Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old No drug interventions prevention 1 completed NCT01207518
Cluster RCT - Evaluating Effectiveness of a Guide and Tools for Influenza Immunization Campaign Planners No drug interventions prevention Not Available unknown_status NCT01249625
The Respiratory Protection Effectiveness Clinical Trial No drug interventions prevention Not Available completed NCT01207557
A Randomized Controlled Trial of the Effectiveness of the Ottawa Influenza Decision Aid No drug interventions prevention Not Available completed NCT01227967
Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications treatment 2 completed NCT01232868
Systems Biology of Trivalent Influenza Vaccine (TIV) in Young and Elderly basic_science Not Available completed NCT01181323
Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women No drug interventions prevention 2 completed NCT01215669
Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in Korea prevention 4 completed NCT01224301
School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities No drug interventions health_services_research Not Available completed NCT01196026
Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™ prevention 4 completed NCT01158326
Evaluation of Efficacy and Safety of Oral Solution Resfenol in Reducing Symptoms of Common Cold And Flu No drug interventions treatment 3 completed NCT01162122
Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects prevention 3 completed NCT01113580
A Clinical Trial of CSL's 2010/2011 Formulation of Enzira® in a Healthy Adult Population No drug interventions prevention 4 completed NCT01106196
The Role of Influenza as a Trigger for Acute Myocardial Infarction: a CALIBER Study No drug interventions Not Available Not Available completed NCT01111968
Evaluation of Pandemic Influenza A (H1N1)Candidate Vaccines No drug interventions prevention 1 completed NCT01100294
Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children No drug interventions prevention Not Available completed NCT01114620
Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older No drug interventions prevention 4 completed NCT01079273
Clinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy Subjects No drug interventions Not Available 4 completed NCT01069874
Trial of Vitamin D Supplementation for the Prevention of Influenza and Other Respiratory Infections (ViDiFlu) No drug interventions prevention 2 / 3 completed NCT01067404
TIV Infant/Toddler Response Evaluation (TITRE)- Follow-up & Focus on Influenza B No drug interventions Not Available Not Available unknown_status NCT01053663
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza treatment 1 terminated NCT01050257
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza treatment 3 completed NCT01037634
Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age treatment 2 withdrawn NCT01044095
Study of Seasonal Influenza Vaccine Against H5N1 Avian Influenza Virus basic_science Not Available completed NCT01056380
Study of Nitazoxanide in Adults With Acute Uncomplicated Influenza treatment 2 terminated NCT00995826
Safety, Tolerability and Pharmacokinetic Study of Multiple Doses of CS-8958 treatment 1 completed NCT01037829
Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety Study No drug interventions Not Available Not Available completed NCT01032980
Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and Adults No drug interventions Not Available Not Available completed NCT01033734
A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza treatment 1 completed NCT01006681
Vaccination Against Influenza H1N1 in Rheumatic Diseases No drug interventions prevention 2 unknown_status NCT01024673
Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1) No drug interventions Not Available Not Available completed NCT01039220
Incidence of H1N1v Influenza-like Illness and Risk Factors for Serious Influenza Forms in HIV Infected Patients No drug interventions other Not Available completed NCT00958126
A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults in the USA No drug interventions prevention 2 completed NCT00956046
A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months No drug interventions prevention 2 completed NCT00976469
A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents No drug interventions prevention 1 / 2 completed NCT00975572
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older No drug interventions prevention 2 completed NCT00988325
A Pharmacokinetic/Pharmacodynamic (PK/PD) and Safety Evaluation of Oseltamivir [Tamiflu] in the Treatment of Infants 0 to <12 Months of Age With Confirmed Flu Infection treatment 1 completed NCT00989612
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) No drug interventions prevention 2 completed NCT01000831
Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children No drug interventions prevention 4 completed NCT00989274
Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1 No drug interventions prevention 2 withdrawn NCT00988143
A Study of Influenza Virus Vaccines in Children and Adults prevention 2 completed NCT00976027
Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone® Vaccine in Adults Aged 65 Years and Older prevention 3 terminated NCT00980850
Swine Flu (Novel Influenza A H1N1) Vaccine Study prevention 2 completed NCT00985673
Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults No drug interventions prevention 2 completed NCT00959465
A/H1N1 Immunogenicity and Safety in Adults No drug interventions prevention 1 / 2 completed NCT00979667
A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection treatment 3 terminated NCT00968539
Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults No drug interventions prevention 3 completed NCT00921726
Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adults treatment 1 completed NCT00900991
Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children No drug interventions prevention 2 completed NCT00963157
Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations No drug interventions prevention 2 completed NCT00972816
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years) No drug interventions prevention 2 / 3 completed NCT00953524
A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly No drug interventions prevention 2 completed NCT00952276
A Study of Different Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly No drug interventions prevention 2 completed NCT00943631
Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations No drug interventions prevention 2 completed NCT00920374
A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults prevention 3 completed NCT00943657
Yearly Strain Variation Study, 2009/2010 No drug interventions prevention 3 completed NCT00943358
Safety and Immunogenicity of A/H1N1v Vaccines in Healthy Adults No drug interventions prevention 1 completed NCT00945438
Study of the Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (Intradermal Route) No drug interventions prevention 2 completed NCT00952419
A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years No drug interventions prevention 2 completed NCT00895544
Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults No drug interventions prevention 1 / 2 completed NCT00884117
Influenza Resistance Information Study Not Available Not Available completed NCT00888381
A Study to Assess the Immunogenicity and Safety of CSL's 2009 / 2010 Formulation of Enzira® Vaccine in Healthy Volunteers No drug interventions prevention 4 completed NCT00884182
Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children No drug interventions prevention 2 completed NCT00873886
A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy basic_science 1 withdrawn NCT00877396
Hutterite Influenza Prevention Study prevention 4 completed NCT00853255
Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adults prevention 1 completed NCT00866580
A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine No drug interventions prevention 3 withdrawn NCT00868218
Study of a Parenterally Administered H5N1 Influenza Vaccine in Healthy Adults No drug interventions basic_science 1 completed NCT00851266
A Study of a Bivalent Influenza Peptide Conjugate Vaccine in Healthy Adults No drug interventions prevention 1 completed NCT00835926
A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination prevention 4 completed NCT00814229
Safety and Immunogenicity of Influenza H9 Vaccine in Humans No drug interventions basic_science 1 completed NCT00821626
Rapid Flu Tests in Travelers With Fever No drug interventions diagnostic Not Available completed NCT00845429
Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects prevention 2 completed NCT00812981
A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine. No drug interventions prevention 3 completed NCT00798343
Heterosubtypic Immune Responses to Influenza in Older People No drug interventions basic_science 1 completed NCT00776438
Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines prevention 2 completed NCT00775450
Influenza Vaccine Revaccination in Ambulatory Elderly Subjects prevention 2 completed NCT00782431
Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older No drug interventions prevention 3 completed NCT00718146
Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation No drug interventions prevention 2 completed NCT00765076
Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older prevention 3 completed NCT00760617
Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older prevention 3 completed NCT00754455
Evaluate the Safety and Immunogenicity of a Seasonal Influenza VLP Vaccine (Recombinant) in Healthy Adults No drug interventions prevention 2 completed NCT00753272
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older prevention 3 completed NCT00750360
Study to Monitor the Safety and Reactogenicity of Fluarix™ in Korean Subjects Aged > 6 Months of Age. No drug interventions prevention 4 completed NCT00748150
Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects No drug interventions prevention 2 completed NCT00680069
H5N1 (Clade 2) Vaccination of Adults and Elderly No drug interventions prevention 1 / 2 completed NCT00730457
Phase 1 Safety and Immunogenicity Study in Healthy Adults of VAX125, a Recombinant HA-flagellin Influenza Vaccine No drug interventions prevention 1 completed NCT00706563
A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults prevention 3 completed NCT00664417
Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine No drug interventions prevention 1 completed NCT00731029
Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03 prevention 3 completed NCT00695669
A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64 prevention 2 completed NCT00636662
FLU A+B Nasal Swab Clinical Study No drug interventions Not Available Not Available completed NCT00617318
Pomegranate Products for Prevention of Common Cold No drug interventions prevention 3 completed NCT00610935
Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza treatment 3 terminated NCT00540592
Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A prevention 2 completed NCT00545701
Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults No drug interventions prevention 2 completed NCT00538473
Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults prevention 2 completed NCT00524940
Trial to Describe the Safety and Immunogenicity of Fluzone® prevention 2 completed NCT00517517
Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived) No drug interventions prevention 1 / 2 completed NCT00516035
Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults prevention 1 completed NCT00530660
Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501) No drug interventions prevention 2 completed NCT00488046
Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults No drug interventions prevention 1 completed NCT00492063
Safety and Immunogenicity of a Cell Culture-derived Influenza Vaccine in Healthy Adults and Elderly No drug interventions prevention 3 completed NCT00479648
A Phase 2 Study of Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants No drug interventions Not Available 2 completed NCT00510874
Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults No drug interventions prevention 1 completed NCT00448773
REDucing Influenza Among University Students, University of California at Berkeley No drug interventions prevention 4 completed NCT00440362
A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza No drug interventions prevention 1 / 2 completed NCT00436124
A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza. treatment 4 terminated NCT00439335
Higher Dose Intradermal H5 Vaccine prevention 1 / 2 completed NCT00424086
Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) No drug interventions prevention 1 / 2 completed NCT00428831
Clinical IGSP-CHOP Boston No drug interventions Not Available Not Available completed NCT00419224
Influenza Vaccination in Bone Marrow Transplantation No drug interventions prevention 4 completed NCT00419263
Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza. treatment 2 completed NCT00436046
Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally No drug interventions prevention 1 completed NCT00385840
Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate No drug interventions prevention 2 completed NCT00415129
Safety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the Elderly No drug interventions prevention 2 completed NCT00417560
Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses prevention 1 / 2 unknown_status NCT00412555
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children. prevention 4 completed NCT00383539
Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults prevention 3 completed NCT00385281
Proteomic Profiling for Influenza Vaccination - FluMist prevention 4 completed NCT00372255
Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years No drug interventions prevention 4 completed NCT00343681
A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine No drug interventions prevention 2 completed NCT00345904
Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above prevention 3 completed NCT00347672
Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults No drug interventions prevention 1 completed NCT00349141
Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived) No drug interventions prevention 1 / 2 completed NCT00354016
Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects No drug interventions prevention 3 completed NCT00342940
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older No drug interventions prevention 2 withdrawn NCT00335855
Pharma-Pen (Formerly Innoject) Auto-injectory TIV No drug interventions prevention 1 withdrawn NCT00296634
H5 Vaccine Alone or With Adjuvant in Healthy Adults prevention 1 / 2 completed NCT00297050
Safety and Dose Study of Peramivir for Influenza Treatment treatment 1 completed NCT00320346
Phase II Study of Pandemic Influenza Vaccine No drug interventions prevention 2 completed NCT00321373
Study to Evaluate an Influenza Vaccine Candidate No drug interventions prevention 2 completed NCT00329966
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older No drug interventions prevention 2 completed NCT00329927
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects No drug interventions prevention 2 completed NCT00289510
Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived) No drug interventions prevention 1 / 2 completed NCT00311714
Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958 prevention 1 completed NCT00311727
Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine prevention Not Available completed NCT00311701
Chart Review of Antivirals for Influenza in Infants No drug interventions Not Available Not Available completed NCT00258934
Immunogenicity Study of the Influenza Vaccine in Adults prevention 2 completed NCT00309634
Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged Between 18 and 60 Years No drug interventions prevention 1 completed NCT00310648
Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years) No drug interventions prevention 3 completed NCT00310804
Safety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-derived Subunit Influenza Vaccine in Healthy Adults (>=18 to <=60) No drug interventions prevention 3 completed NCT00258817
Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone Vaccine prevention 4 completed NCT00240968
H5 Booster After a Two Dose Schedule prevention 2 completed NCT00231920
Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age prevention 1 completed NCT00217230
Trial To Assess Safety And Efficacy Of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) In Adults Aged 60 Years And Older No drug interventions treatment 3 completed NCT00230750
Inactivated Influenza A/H5N1 Vaccine in the Elderly prevention 1 / 2 completed NCT00192218
Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program prevention 4 completed NCT00192192
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults No drug interventions prevention 3 completed NCT00197301
Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy No drug interventions prevention 1 / 2 completed NCT00221676
Effectiveness of Influenza Vaccination Among General Practitioners No drug interventions prevention 4 completed NCT00170508
Young Adult Influenza Vaccine Immunogenicity Substudy prevention Not Available completed NCT00192166
Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months No drug interventions prevention 2 completed NCT00192140
Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age treatment 4 completed NCT00170443
Trivalent rHA Dose Escalation Study in Elderly Subjects No drug interventions prevention 2 completed NCT00158665
A Comparison of One Versus Two Doses of Influenza Vaccine in Children 5-8 Years of Age No drug interventions prevention Not Available completed NCT00138294
Control of Epidemic Influenza Through a School-based Influenza Vaccination Program prevention 4 completed NCT00155974
Rapid Vaccination of Hard-To-Reach Populations No drug interventions prevention Not Available unknown_status NCT00133523
FLU-VACS Comparative Study in Adults No drug interventions prevention 4 completed NCT00128167
Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age prevention 3 completed NCT00133510
Influenza Vaccine in Pediatric Transplant Subjects prevention 4 completed NCT00115531
Eldery High Dose TIV 2005 No drug interventions prevention 2 completed NCT02610478
Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A No drug interventions treatment 3 enrolling_by_invitation NCT06385821
A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus No drug interventions prevention 3 completed NCT03293979
Alere i FluA*B Biologic Test Relocated in Emergency Service for Flu Diagnosis No drug interventions Not Available Not Available completed NCT03189537
Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections prevention 3 completed NCT01459952
A Double-blind, Randomised, Parallel Group,Comparative Study With Rose-hip Liquid and Placebo Given to Healthy Volunteers in the Winter Season Aiming to Evaluate the Occurences of Flu and Catching a Cold No drug interventions prevention 3 completed NCT03212716
Efficiency of Antagonist Drugs of the Cellular Transcriptomic Signature of Influenza A Virus Infection. treatment 2 terminated NCT01533220
Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal treatment 3 completed NCT06057727
Behavioral Economics to Improve Flu Vaccination Using EHR Nudges No drug interventions health_services_research Not Available completed NCT05435144
Elderberry for Immune Support No drug interventions prevention Not Available recruiting NCT00644540
Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study No drug interventions prevention 2 completed NCT03769012
Ability of Beta-glucan Supplementation to Augment Immune Function No drug interventions other Not Available completed NCT03694808
FLUAD vs. FLUZONE HD Influenza Vaccine in Residents of Long Term Care treatment 4 completed NCT01302990
Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults No drug interventions prevention 1 completed NCT00769002
PET-CT Scans in Healthy Volunteers After Flu Vaccination No drug interventions health_services_research Not Available terminated NCT02822105
Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers No drug interventions prevention 1 completed NCT01440205
Licensing Flu Shot Study No drug interventions prevention Not Available completed NCT05417997
Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients treatment 3 completed NCT06158659
Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula No drug interventions supportive_care Not Available recruiting NCT01315418
Effect of the Consumption of a Fermented Milk on Common Infections in Adults Submitted to Multi-stressor Situation No drug interventions basic_science Not Available terminated NCT01389518
Efficacy and Safety of Paracetamol, Chlorpheniramine and Phenylephrine in the Treatment of Common Cold and Flu Syndrome No drug interventions treatment 3 completed NCT05473325
Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY) No drug interventions Not Available Not Available not_yet_recruiting NCT04153331
Burden of Influenza at Emergency Department Level : BIED No drug interventions other Not Available completed NCT04515446
Quantification of Viral Load in the Upper Respiratory Tract in Patients Treated With Olsetamivir for Influenza No drug interventions diagnostic Not Available unknown_status NCT02188810
Safety and Reactogenicity of a PAL Combined With Seasonal Flu Vaccine in Healthy Adults prevention 1 unknown_status NCT03345043
Safety, Tolerability, and Immunogenicity of VAL-339851 in Healthy Adult Subjects No drug interventions prevention 1 completed NCT06574503
Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza No drug interventions treatment 3 not_yet_recruiting NCT00240903
Revaccination With Subunit Influenza A/Vietnam/1203/2004 (H5N1) Vaccine prevention 1 completed NCT00764790
Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children prevention 3 completed NCT01408290
Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly People No drug interventions prevention Not Available completed NCT05661890
Seasonal Influenza and Pneumococcal Vaccination in the Elderly No drug interventions Not Available Not Available completed NCT00985790
Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children prevention 2 completed NCT01755364
A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old prevention 3 completed NCT03653364
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms treatment 3 completed NCT02206464
H7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boo... No drug interventions prevention 1 completed NCT06460064
First-in-human Study to Assess the Safety, Tolerability and Immunogenicity of the Adjuvanted Universal Influenza Vaccine fH1/DSP-0546LP No drug interventions prevention 1 recruiting NCT05787964
Immunity to Infection in Healthy Participants and Participants With Cancer No drug interventions Not Available Not Available active_not_recruiting NCT04729764
Evaluation the Safety and Tolerance of GP681 Tablets in Healthy Subjects No drug interventions treatment 1 completed NCT06062264
Patient Portal Flu Vaccine Reminders (RCT 6) No drug interventions health_services_research Not Available active_not_recruiting NCT06076421
Equity Evaluation of Fact Boxes on Informed COVID-19 and Influenza Vaccination Decisions - Study Protocol No drug interventions health_services_research Not Available recruiting NCT01227421
Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza treatment 2 / 3 completed NCT00971321
Safety, Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A) No drug interventions prevention 2 completed NCT02587221
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age prevention 3 completed NCT00430521
Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A) No drug interventions prevention 2 completed NCT02567721
Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK) No drug interventions Not Available Not Available completed NCT01867021
Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above prevention 4 completed NCT02249221
Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine) No drug interventions prevention 1 / 2 completed NCT02557802
T-cell Diversity Following Intranasal and Intramuscular Vaccines Not Available Not Available completed NCT00561002
Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine prevention 4 completed NCT00979602
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older No drug interventions prevention 3 completed NCT01157702
Yearly Strain Variation Study, 2010/2011 No drug interventions prevention 3 completed NCT00943202
Sanofi Pasteur, TIV + H1N1, Pediatric Population No drug interventions prevention 2 completed NCT00091702
Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents prevention 1 / 2 completed NCT01047202
Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants prevention 4 completed NCT01676402
Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years prevention 1 completed NCT04576702
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults No drug interventions prevention 2 completed NCT02134184
The Influence of Chronic CMV Infection on Influenza Vaccine Responses basic_science 4 completed NCT01000584
Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza Vaccine prevention 4 completed NCT00784784
Zanamivir Versus Trivalent Split Virus Influenza Vaccine prevention 3 completed NCT01712984
Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years prevention 3 completed NCT03629184
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like Symptoms treatment 3 completed NCT05436184
Influenza IMPRINT Cohort: Defining the Impact of Initial Influenza Exposure on Immunity in Infants No drug interventions Not Available Not Available recruiting NCT01251679
Household Influenza Transmission Study No drug interventions prevention Not Available completed NCT01496079
Maternal Immunization: Giving Immunity For Tomorrow No drug interventions Not Available Not Available completed NCT00946179
Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation No drug interventions prevention 2 completed NCT00192179
A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years. No drug interventions prevention 2 completed NCT01195779
Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children prevention 2 terminated NCT00111579
Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV) No drug interventions treatment 2 completed NCT01262079
Evaluation of Influenza-Specific Immune Responses in Children and Adults During the 2010-2011 Influenza Season in the U.S. No drug interventions Not Available Not Available completed NCT02255279
Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in Mexico. No drug interventions prevention 3 completed NCT05126979
The Objectives of This Study Are Study of the Reactogenicity, Safety and Immunogenicity of Flu-M Inactivated Split Influenza Vaccine in Volunteers Aged 18-60 Years No drug interventions prevention 1 completed NCT00719043
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years prevention 2 completed NCT03679143
The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers. No drug interventions treatment 1 completed NCT02719743
A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age prevention 2 completed